Said in CommitteeBeta

Exactly as spoken.

House Public Health, Welfare and Labor Committee

March 19, 2015
Video Transcript

Bills discussed (8)

Bill Title Sponsor Status
HB1491 · 3 mentions in chapter, transcript
Matched: “HB1491”
Pre-2017 bill
HB1343 · 2 mentions in chapter, transcript
Matched: “HB1343”
Pre-2017 bill
HB1540 · 1 mention in chapter
Matched: “HB1540”
Pre-2017 bill
HB1555 · 1 mention in chapter
Matched: “HB1555”
Pre-2017 bill
HB1747 · 1 mention in chapter
Matched: “HB1747”
Pre-2017 bill
HB1953 · 1 mention in chapter
Matched: “HB1953”
Pre-2017 bill
SB133 · 1 mention in chapter
Matched: “SB133”
Pre-2017 bill
SB688 · 1 mention in chapter
Matched: “SB688”
Pre-2017 bill

Official video page ↗

Transcript

Transcript available Whisper ✓ SliQ live captions: not yet available Download .txt
Machine transcript

May contain errors. Verify important quotations against the official video.

About transcript accuracy
Source
Whisper
Model
ggml-large-v3-turbo.bin RTX5060
Processing date
October 15, 2026
Unknown speaker 0:00
Good morning, Josh.
▶ Play
all right members um everyone else we appreciate your patience of our of our time frame being nine o'clock in the morning we know we're in conflicts from other things we know we kind of changed the time back and forth a little bit till we got all the confusion over with but uh we need to get started at nine o'clock so we can get done around noonish today we have five special orders of business, but I've promised three very short presentations, first of which is Representative Fielding, who would like to move, I believe, his bill, who'd like to explain his bill and then possibly move it for interim study. Is that right? That is right, Mr. Chairman. And what is your bill number? My bill is 1953. 1953, Representative Fielding, you're recognized
▶ Play
to, we'll say, present your bill. Thank you, Mr. Chairman. Thank you, Committer. The committee, I've talked to those parties that's involved, and this bill is there with creating the cosmetologist board back and talking to the parties. There's a lot of work, a lot of doubt that need to go through. So I would like to request the committee that I'll pull this bill back and send it to interim study. And you guys should do that
▶ Play
on the floor. All right, members, you've heard this, and Representative Fielding, you know you can do this on the House floor, and that's why we're going to have you do that, so we don't need a motion to this committee. I do want to point out, especially to the first-term people in this committee, that this interim study is a great thing to use when you've got problems with your bill, rather than trying to force it through and getting beat or maybe getting through a bill that's not really good for anything. It's a great time to look at it over the next couple years during the interim. A lot of people send it to interim study just so they don't have to do it anymore, but I think Representative Fielding is going to work that in the interim. It's going to work out problems. It's going to be a good thing, and it's a great process to use. So, Representative Fielding, thank you for having the care to work this bill through and get it right for next term. Thank you, Mr. Chairman. Thank you for that opportunity. Thank you, committed. Representative Lindstrom, you're recognized. Your bill number is 1540. Thank you, Mr.
▶ Play
Chairman. As you can see, you have a few amendments on the bill. We've added sponsors. Oh, microphone. I'm sorry. As you can see, we've added some sponsors and some legal language on an amendment. If I could get the committee to take a look at that. We have an amendment?
▶ Play
1540. We don't see the amendment on the tablet, Representative Lindstrom. I'm sorry. it will be there in
▶ Play
a moment as I understand right as that's pulling up this is simply a employment law change right now in the state of Arkansas you have to meet three requirements plus the IRS code all we're asking is that we meet the IRS code plus the first requirement for Arkansas law and the second one or the third so we're changing one word why this is important right now is in Arkansas, if you are an independent contractor, you're a ditch digger. It doesn't matter what you do, but if you're an independent contractor, it's very difficult to become an independent contractor, and what it's doing is choking off the market, and it's costing us jobs.
▶ Play
Okay, the amendment should be coming up on your tablet now, members. Alright, any questions about the amendment? Seeing none, will the committee as to adopt the amendment? All those in favor say aye. Any opposed? The amendment's adopted. You're recognized. Present your bill as amended, Representative Lindstrom, 1540. Thank you. I
▶ Play
think the explanation I've given you is pretty good. If anybody has any questions, I'll be glad to entertain those. Members, any
▶ Play
questions? Representative Boyd, you're recognized. Any members, any questions? Seeing no questions, anyone signed up to speak for or against this? Seeing none, is there anyone from the audience wishing to speak for or against this? Seeing none, what's the will of this committee? We have a motion do pass from somewhere. Representative Boyd, all right. Any discussion of that motion? Hearing or seeing none, all in favor say aye. Aye. Any opposed? Congratulations, your bill has passed. Representative Whitaker, your bill number is? 1491. You should go on the radio business.
▶ Play
You don't even need a radio.
▶ Play
Thank you, Mr. Chair. I tried it. It didn't
▶ Play
pay. Like this does? Oh, yeah. Mr. Chairman, if I may ask to accompany me here at the table, legal counsel for Washington Regional Medical
▶ Play
Speaker 31 5:44
Center, Mr. Tom Olmstead. Very quickly, very briefly, what you have
▶ Play
before here is the cleanest, most efficient bill that we could craft to allow non-profit hospitals in Arkansas to offer dental care to indigent citizens. hospitals in the state have been offering charitable dental practice but the law was very mixed up on whether that was even legitimate we wanted to clean it up we wanted everybody to be able to operate out in the sunshine and we want to make sure that their insurance carriers and everybody involved knew that this was legal and that it was under the authority of the Arkansas Dental Board and with that I will turn it over to Mr. Olmstead to kind of give you background
▶ Play
and the hospital's take on this bill. Hi. My name is Tom Olmsted. I am the General Counsel for Washington Regional Medical Center, and I appreciate the committee's time in permitting me an opportunity to advocate for passage of House Bill 1491. As Representative Whitaker said, House Bill 1491 would permit only non-hospital or nonprofit hospitals to own, operate, and manage dental clinics in the state of Arkansas and to employ dentists. The bill would assure that the state dental board would continue to have oversight and regulatory authority over the nonprofit hospital's operation of a dental clinic, and it would further require that a dentist licensed by the state be in charge of supervising the operation of the clinic. We believe that House Bill 1491 is a win in that it improves access for adults who are uninsured and less fortunate in this state to preventative dental care, which often is unavailable to them at this time. It improves the cost to the state Medicaid system because the situation as we currently find it, oftentimes adults wait to get care until such time as their condition has gotten to the point where they require an emergency room, and the cost to the Medicaid system of folks coming into the ED where the services that we can provide consist of teeth extraction, prescribing antibiotics, or prescribing pain medication is much more costly than it would be if we could afford that care in an outpatient setting. We also believe that it would improve the operation and efficiency of nonprofit hospitals' emergency departments and that it would allow folks who are coming for non-urgent conditions, dental care, to receive that care outside of the ED. Nationally, we're seeing an increasing number of folks who are seeking dental care in the ED. That's happened at Washington Regional. We now see that the 10th most common reason someone presents to our ED is related to dental conditions. numerous studies several of which I believe I sent to the members of the committee show that this is a problem that is increasing nationally the American Dental Association issued a report in May of 2013 entitled dental related emergency department visits on the increase in the United States that highlighted the fact that visits had increased from 1.1 million in 2000 to 2.1 million in 2010, and that nearly 90% of the conditions that are being seen, dental-related conditions that are being seen in hospital emergency departments are things that could be better cared for in an outpatient setting, where if they had good preventative care, they wouldn't have to come into the emergency department for chronic conditions. Our personal experience was that in 2012, Walmart Foundation and the University of Arkansas's sociology department approached us recognizing this problem and asked us as a charitable institution to purchase and operate a mobile dental facility. And Walmart Foundation graciously appointed $600,000 for that purpose. And when Washington Regional acquired the van and started figuring how we were going to make this operate, we came into contact with the Arkansas Dental Corporations Act and the Dental Practices Act, which forbids any entity other than a licensed dentist or a corporation owned entirely by dentists to own, operate, and manage a dental clinic or to employ dentists or dental hygienists. So we, through a series of legal contracts and some very generous dentists in our community who are willing to tie their dental practice to our dental van and a dentist who is willing to provide his services pursuant to an independent contractor relationship to the hospital were able to get the approval necessary to operate our dental van. But as we recruited dentists to staff the unit, what we found was many of them wanted the opportunity to be employed by the hospital so that they could access our employee welfare benefit plans and not have to form their own dental practice for the purpose of helping us run the dental unit and unfortunately we had to tell many of those dentists that we weren't in a position to employ them. So what this law hopefully will do is create a more stable situation for the nonprofit hospitals who are currently operating dental clinics in Arkansas so that they have the legal authority to cleanly operate those. Just a few statistics about
▶ Play
our dental facilities. President Whitaker? I'm sorry this is not opposed to
▶ Play
your knowledge, is it? Not to my knowledge, but I'm not all-knowing. I understand. Representative
▶ Play
Lindstrom? I'm willing to make a motion at the proper time. I think this
▶ Play
is good. We can go. I'm sitting beside a dentist who says this is not opposed, and I appreciate all the testimony, but I've got five special orders of business.
▶ Play
Absolutely, and I think with the pleasure of the committee and certainly the pleasure of the chair members
▶ Play
any questions seeing seeing none there's no one sign to speak for against this bill what's will this committee or assume your clothes represent Whitaker I am closed very good what's will this committee we have a motion we do pass from representative Lundstrom do we have a discussion that motion seeing or hearing none all in favor say aye any opposed and thank you thank you represent fight your first Special Order of Business.
▶ Play
Thank you, Mr. Chair. Thank you, Committee. Give me just a moment to pull this up, please. I did not bring my hard copy. This is House Bill 1343 that I brought to you several weeks ago, and you had asked for some additional information, so I'm here today with that information for you. I have with me Mr. Jerry Richards. May I bring him to the table, Mr. Chair? Yes, please. Thank you.
▶ Play
Speaker 60 13:21
My name is Jerry Richards, and I thank you for the opportunity, Mr. Chairman, for allowing me to come and address the committee, and also to answer any questions that you may have. And I, by the way, I am a member of the regulatory board for hearing instrument dispensers and have been for six years.
▶ Play
Members, any questions? Representative makes you recognized. I was trying to wrap my head around why this bill went out and came back in. I think the question was how much money did they have in their fund, and I don't think that we ever got an answer as to far
▶ Play
Speaker 66 14:14
as how much they had in their
▶ Play
fund to be able to administer the test. You're right, Representative Meeks. The questions brought up about this is there's a fee doubling from $150 to $300 for the written examination, and then the question was how much money is currently in the cash fund. And there wasn't an answer for that. So can you answer
▶ Play
Speaker 60 14:35
those questions? I certainly can. Let me give you a brief background of what we're trying to accomplish here. The International Hearing Society is the agency. Am I loud enough? You are, but would
▶ Play
you go ahead and answer the question? How much money is in your cash fund? $77,000. $77,000. And how long do you think that that would keep you going? Not with what we
▶ Play
Speaker 60 15:08
are trying to accomplish, not very long, sir. Not very long, Mr. Chairman. And that's what I would
▶ Play
like to explain. Okay. All right. Well,
▶ Play
Speaker 60 15:18
let's hear that explanation. Okay. Let me explain why first we're trying to do the change, and then I will explain to you where the money that we have in the fund came from and the reason for that. And this is something that is very important to be answered. The International Hearing Society in the past has provided a written examination that they provided to our board, and our board administered that exam. We paid the International Hearing Society, if I'm not mistaken, $95 for that exam, that written exam. The board administered that exam, and we charged the person sitting for the board, the individual that was trying to become a hearing health care provider, we charged them $150. So every time we gave an exam, we were netting $55, in essence, that was going into our account. The International Hearing Society now is going to an off-site testing. They are charging the applicant, the individual that is wishing to become a hearing health care provider, $225 to set for that board. We are not accruing one dime from that particular amount of money. And the reason why it's not going to $300, the reason we asked for $300 was because if the International Hearing Society raises the fee once again, we didn't want to have to be here next year to ask for $25 more if that's what they raised the fee to. So what is happening now is if you are an applicant who have met the requirements to set for the state board, you will pay the International Hearing Society $225 to set for the board. And it will be at off-site locations. It will not be administered in just one location. It will be at off-site locations across the state, also many locations in Memphis. Now, in terms of why we accrued the money, what our thinking was, quite frankly, in the past, I've been on the board six years. When I first was appointed to the board, our board was broke. We had no money. We had no money to the point that even our executive director was volunteering a lot of her time to provide services for our board. Our board members were not getting any mileage for travel from their home to the board meetings that we have quarterly. We had no money. I mean, we were scraping by. What we wanted to do is we had two things that we knew were coming up. We had the executive director, current executive director, who has been for over 25 years. She is retiring. We are having to replace her, and we knew there would be expenses in getting this set up. But more importantly, we wanted to hire an investigator for our board, and we did not want to use any government funds. We did not want to use any public funds. We want to be self-cash, yeah, self-policing, and we want to use the funds that we have accrued in order to do this. Now, you might wonder where the funds came from. The funds that we have accrued have come from primarily two sources. The first source is the renewal of licensure. And the best that I can tell, that accounts for about 15% of the cash fund. The second amount comes from a change in our rules from about three or four years ago where we started charging manufacturers $50 per continuing education hour for us to approve their continuing education hours. So the money that we have accrued has come from outside of this state, most certainly, and from manufacturers who wish to have their continuing education hours approved by our board. That is where the vast majority of the money has been accumulated. Now, just recently, the House, I believe, passed our new, what is it called? My mind went blank, the bill that we just did. Appropriation. Big word, I can't remember. Appropriation. To allow us to hire this investigator that we wish to hire and to be able to set up a new individual to act as executive director. So this is our thinking, okay? This is what we are trying to accomplish. This is what we have been trying to accomplish for the last two or three years, and I would be happy to answer any questions.
▶ Play
Representative Meeks, I kind of recognize you sort of as a follow-up. Thank you, Mr. Chair. Because, you know, you said the test is $225. I understand that you were wanting to do the inspector, but the bill does, because I was going to ask a question about could you just charge $225. The bill says not to exceed $300. So is there any plan to charge $225 because that's the price of the test, and then if it increases next year, or do you plan on just doing the $300 and pocketing the extra $75?
▶ Play
Speaker 60 21:37
No, sir. The way this, and I appreciate that question, But the way this system works is actually, let's say you were qualified, you had met the qualifications of the board to set for the exam. You actually go online and you pay the International Hearing Society the $225 when you register. And then you pick the time that you wish to go set for the exam. It will be whatever the International Hearing Society charges. In other words, they don't pay us, and then we pay the International Hearing Society. They pay the International Hearing Society directly. So it will be $225 unless the International Hearing Society raises that fee. Another, well, let me just ask if there's any other questions. Did that answer your question, Representative? I'll come back to you in a
▶ Play
moment. Representative, will I have you recognized?
▶ Play
Representative Feit, I'm going to pick up where our colleague left, Representative Meeks, because I thought it was my understanding initially that you all were administering the test, and so this was part of the $300 fee. But what you have just explained is that they have to register for the test individually and they are assessed a $225 fee. So what you're doing is you're charging an administration fee for the test. They've already paid
▶ Play
Speaker 60 23:21
for the test. The test is $225 now, correct? That is correct. But that is not to us. That is to international
▶ Play
hearings. Yes, I understand. But are you saying that you're going to charge a $300 sitting
▶ Play
Speaker 60 23:34
fee to administer the exam? No, we don't administer. Representative, we don't administer the exam anymore. They're going to off-site testing. It's a completely different, there are going to be six, I think six locations across the state that are going, they will not.
▶ Play
It's just like administering the ACT. That's correct. You register for the test, okay.
▶ Play
Speaker 60 23:57
But we're not charging any fee other than what IHS, International Hearing
▶ Play
Society, charges. Okay, so what is the $300 assessment
▶ Play
Speaker 60 24:07
for, I mean. The $300, the reason we ask for $300 is because right now the fee for the International Hearing Society is $225. That is what they will be paying. Not to us, to the International Hearing Society. The reason we ask for $300 because let's say hypothetically that next year the International Hearing Society decides they're going to charge $235. We don't want to have to come back in here and ask you for an increase to $235 when we're setting a $300 boundary. So if the International Hearing Society raises their fee, then we will still be within the law, okay? And by the way, the only reason we're doing this is because the other option is history, okay? I mean, the only way we're going to be able to allow individuals to sit for the board and have an entryway into our profession is through this new testing procedure. We have no other option. And we would not be here asking for an increase if that was not
▶ Play
the case. Okay. Follow-up, Mr. Chair? Yes, sir. Okay. I have the two pieces, but I don't have the middle. Okay. Because you're saying that the individual pays the $225 to the people that have the test. That's correct. You're saying that you want to be able to charge a fee and you don't want to come back here, so you set
▶ Play
Speaker 60 25:49
it at $300. No, sir. No, that's not what I'm saying at all. I'm
▶ Play
saying, yes, let me. No one is getting $300. They're setting a cap of $300 so in case the International Hearing Society raises their fees as high as $300, they don't have to come back here and keep asking, but nobody's getting $300. Did that help? Nobody's getting that. Yes, you're recognized for follow-up. This is just like saying if the maximum, like right now, you're going to be paying $10 for something, but next year it might go to $12, the next year it might go to $15. I'm going to say right now we're going to charge you $20 just in case this goes up so every year I don't have to keep coming back and saying we need $2 more, $2 more. But nobody's going to be paying that at
▶ Play
Speaker 95 26:45
this point. May I, Mr. Chairman, may I expound on that just a
▶ Play
Speaker 60 26:51
moment? Yes, please. Okay. The most important thing that I want to make sure that everyone understands, and I understand, quite frankly, where the confusion comes from. I really do. But the most important thing to understand is that this fee that we are talking about is determined by the International Hearing Society, not by our regulatory board. Right now, they have that fee set at $225,000. So if you, Mr. Representative, if you were able and qualified at this point, according to our board, to sit for our board, and you had met the requirements to do that, you would go online to the International Hearing Society site. You would register, you would pay them your $225, they would administer the exam at an off-site location, and then they would send us, the board, the results of that exam. There will not be anything more charged to that person that is sitting for the board at any time unless the International Hearing Society decides to raise their fee. And we have a little wiggle room, for lack of a better term, we have a little wiggle room there where we don't have to come back and waste your time asking for an additional amount of money if they raise their fee. If they don't raise their fee, if they stay at $225, that's
▶ Play
what it will remain. I've got
▶ Play
Representative Sullivan, then do you, Representative Payton. Thank you, Mr. Chair. So your board oversees the Arkansas Society of Hearing. There's a group that you oversee, and you just hired somebody to regulate them. Are they okay with this, Bill? Who's that? The people that you regulate, the Arkansas hearing providers. Our
▶ Play
Speaker 60 29:01
board, let me give you an idea of basis. I'm just interested in. Well, I don't understand your question, sir. Okay, so there are providers. You have
▶ Play
a board. There are providers that you oversee and provide these services for. I understand. Those providers are okay
▶ Play
Speaker 60 29:21
with this bill. Now, you're talking about the individuals that would be sitting for the board.
▶ Play
Speaker 102 29:27
Is that what you're talking? I'm talking about the people that you oversee. Well, the people that we oversee
▶ Play
Speaker 60 29:38
currently are already licensed. Thank you, Mr. Chair. Yes, sir. I'm bringing this on behalf of the board. Now, if you're asking about what an applicant might think of that, paying an additional $75, I think they would be, quite frankly, thrilled because it behooves them to be able to not only take the exam when they wish to, but also to get the results of the exam expeditiously where now it's taking two to three months to get or at least two months to get the results. They can take the exam off-site, get the results expeditiously, and then retake it if they fail. So from an applicant standpoint, I think they would be thrilled. As far as the people that you're speaking of that we regulate, I'm here on their behalf. I mean, they want, we want to be able to keep our profession thriving. We want people to have an entryway into our profession to create jobs. And due to the hand that we have been dealt by the International Hearing Society, in order to keep this pathway into our profession open, we have to do this. I hope that answers your question. I'm sorry if it didn't. Representative
▶ Play
Payton, you're recognized for a question. Thank you, Mr. Chair. Who made the decision to subject the Arkansas licensees to the International Hearing Society?
▶ Play
Speaker 60 31:11
That's a good question, and that goes back a few years. When I was first licensed on this board in 1986, the executive director of the board was actually one of our colleagues and Hang on just a second. Representative Wardlaw do you have a point of
▶ Play
order? I do. I have a motion. Let's hear your motion. Can I make a motion
▶ Play
and limit debate to five minutes on either side?
▶ Play
Okay. I'll accept the motion. None debatable. All in favor say aye. Aye. Any opposed? Five minutes, Mr. Price. You're recognized to continue. Okay. Well, I'd like
▶ Play
to get to my second question before the five minutes run out. So at some point in history, the board was administering this test theirself. Yeah. You made reference to that earlier. That's correct. A decision was made to sublet that to this International Hearing Society.
▶ Play
Speaker 60 32:15
What prompted that decision, and why did we have to do that? We did that because we wanted to improve the standard. International Hearing Society has the highest standard of testing available for our
▶ Play
profession. So since the board subletted that portion of their responsibility, what is left in the responsibilities of
▶ Play
Speaker 60 32:37
the board? The primary responsibility of the board is consumer protection. The secondary responsibility of the board is to make sure that licenses are issued and that tests are given.
▶ Play
Okay, and one final question. How many of these applicants per year have to be tested? Have to be tested? How many applicants per year do you
▶ Play
Speaker 60 33:01
have? I would guess, and frankly, I don't do that part of the test. I do not give the test myself. Ten or a hundred or a thousand?
▶ Play
Speaker 97 33:08
No, I'm guessing 15 to 20. Fifteen or twenty a year is what we're talking about. Yeah. Okay,
▶ Play
thank you. Thank you, Mr. Chair. And there's no choice at this point. The test just has to be administered by computer or else Arkansas is going to have to come up with our own test,
▶ Play
which would cost a lot more. Representative Ward-Law, you recognize for question. Thank you, Mr. Chair. Representative Flight, I get this wrong every time, by the way. I can never pronounce your name. But could this not be fixed
▶ Play
with an appropriation instead of a law? We did an appropriation, but this is a separate topic here. I think
▶ Play
I saw the appropriation on the floor. I think it was yesterday or it was earlier this week.
▶ Play
Would that not give them the authorization to do what they're trying
▶ Play
to do? We have three minutes left and many other questions, or do you want to close for your bill, Representative? I'm sorry. I should have asked anybody if the audience speak for or against this. There's no one signed up. All right. Representative Fite, you're closed. I'm closed. What's the will of this committee? Representative Fite, seeing no motion. We had one here. I'm sorry. Whose hand? Do you have a motion, Representative Sullivan? You make a motion. Do pass. Okie dokie. All in favor, say aye. Aye. Any opposed? Ayes have it. Thank you. Passed. All right, Representative, Senator Bledsoe, and you're going in the table as well, Representative Ferguson. Senator Bledsoe, you're recognized to present the next, I have to look and see what the bill number. Senate Bill 133.
▶ Play
Mr. Chairman, before we start, may I ask your indulgence to allow Mr. David Ivers to be at the end of the table with us? Absolutely. And,
▶ Play
Senator, I see there's amendments. I think they're engrossed, or are they engrossed with these?
▶ Play
All the amendments, all of my amendments are engrossed.
▶ Play
Okay, all right. Members, all amendments are engrossed. The bill you read is as it is.
▶ Play
All right, thank you so much. Ladies and gentlemen of the committee, I appreciate the opportunity to be before you today. And Senate Bill 133 is a bill that does exactly what the title suggests. It encourages the use of telemedicine, reduces health care disparities, improves access to care, addresses geographic maldistribution of primary care and specialty care, authorizes reimbursement and regulation of services provided through telemedicine. Senate Bill 133 does all of that in three ways. First, it promotes the use of telemedicine so that the citizens of Arkansas, in specifically rural areas, can obtain needed services from specialists in urban areas. This is accomplished by the distant site, and that's defined on page 2, lines 16 through 18. and that is the location of the health care specialist delivering services through telemedicine at the time the services are provided. And then the originating site, and that is defined on page 2, lines 22 through 27, and that is the offices of a health care professional or a licensed health care entity where the patient is located at the time of services that are provided by the health care professional through telemedicine. And it also includes the home of a patient in connection with treatment for end-stage rental disease. And that's like your dialysis patients that get their treatment at home. The originating site, ladies and gentlemen, and this is very important, It includes physicians, nurse practitioners, pharmacies, hospitals, skilled nursing facilities, community mental health centers, psychologists, and clinical social workers, and many others. Second, it makes sure that the application of telemedicine is used in the manner that meets the professional relationship, And that's defined on page 2, lines 28 through 36, and page 3, lines 1 through 14. And that applies to the care provided in person. In the definition of professional relationship, it means at minimum a relationship established between a health care professional and a patient when the health care professional has previously conducted an in-person examination and is available to provide appropriate follow-up. And that care would be, the follow-up care would be when necessary and at medically necessary intervals. Remember, and this is so important, committee, this is only a one-time encounter. That is all this bill is saying, only one time. And you might ask, well, why is that so important? And the reason for that is because the health care professionals, when they enter the clinical years of training, they're trained to perform histories and physicals. The reason is to address not only a patient's complaint, they may go in with a sinus infection, but it's also to detect problems that the patient is unaware of. Checking vital signs, which includes blood pressure, pulse, respiration, just doing that alone can detect a variety of ailments with just these basic things. Young children and older people many times have unknown illnesses detected through the first time they see a health care provider. They are the most vulnerable to unforeseen problems. Children frequently cannot communicate their problems, and older patients have many illnesses that in seeing a caregiver the first time can be detected. That first encounter should be face-to-face and hands-on. That first time, and again, ladies and gentlemen, that first time and only that first time is all this bill requires. After that first encounter to establish a relationship, it is not required to have a professional health care provider on site. Telemedicine technology is really far, far ahead of legislation in all the states, and I think we must be careful what we allow. We can always do more, but reigning in the law after doing too much is very difficult. Third, Senate Bill 133 is needed to make sure that health care services provided through telemedicine are reimbursed by insurance to maintain viability. That seems to be one of the most important things in the explosion of telemedicine, especially in the rural areas. The distant site where the specialist is are already reimbursed by private pay insurance But if this bill passes, the originating site, and that is the part where I believe the rural areas of Arkansas come into play, that originating site will share part of the payment that the distant site receives. In other words, in this bill, the payment can be no less than an office visit, just a plain office visit. But that payment or that reimbursement is shared not only with the distant site, but also with the originating site. And the insurance company will decide who gets what. It might be 50-50, it might be 75%, 25, but that's up to them. This bill was written in order to procure reimbursement at the originating site and not sacrifice basic quality care. Without reimbursement, the viability of telemedicine, especially in the rural areas, is in jeopardy. Because this bill is just the first step in a process, we hope to gain valuable insight before the next session and see if there are any modifications needed in 2017. However, and ladies and gentlemen, this is another very important part of the bill. The language on page 3, line 7 through 9, gives the Arkansas Medical Board the authority to permit additional ways of establishing telemedicine relationships. if the board approves before we come back in 2017. And I would also like to say, just as a side note, there is a prohibition on any type of abortion, drug, surgical, or chemical, and that's on page 3, lines 29 through 31. And also, ladies and gentlemen, I do have permission to say that the governor does support this bill, and I would certainly be delighted to answer any questions. Thanks, Senator
▶ Play
Bledsoe. I'll go with one of the last points you made first. You say that the relationship exists in other circumstances as defined by rule of the Arkansas State Medical Board for health care professionals under its jurisdiction and their patients. With that in mind and the new, it's not Amendment 1, but Ballot Initiative 1 that we're currently writing enabling legislation for. Does a state medical board rule come before this body through rules and regulations? It would first come to this health committee and then come to this body through rules and regulations. Is that right? Yes, sir. So even though the state medical board could change rules, this body would ultimately be responsible for those rules were changed or not, right? Absolutely. Okay. First in order is Representative Meeks. Thank you, Mr. Chair. I've got a couple of questions for you. Number one, on page six, where it says subject to subdivision of the section of health benefit plan, shall reimburse a physician licensed by the board for health care provided on the same basis as the health benefit plan reimburses a physician for a physician. Can you explain in further detail why you're mandating this? Because, to me, it takes away the freedom that a physician might have to negotiate rates for telemedicine.
▶ Play
I'm going to tell you my opinion, then I'm going to let Mr. Ivers add on to that. But the reason for that was because this bill is aimed for the rural areas. And we have placed so many things on our small-town docks that for them to have the ability to invest in this really sophisticated equipment, this is not just your Skyping or your FaceTime. This is secure, real-time, sophisticated equipment. and it was just felt that they would be able to invest in this equipment. And, again, we're not talking about a lot of money. As I said, it's an office visit. It cannot be less than an office visit, but it's shared also with the distant site, which is the specialist. But it would encourage them to use telemedicine. And, for instance, I think that there are a lot of family practitioners out there that feel very isolated and very alone. And, you know, sometimes they're trying to make a diagnosis, and they may be the only doctor within quite a few miles. And so this would be so important not only to the physician but also to the patient who, if the physician says, well, I'm really not comfortable with this, I'm here by myself, I have no backup, I have no one to ask, you know, is this what I think it is, then they would have to, he would say to them, you're just going to have to go to, and you might go to UAMS, you might go to wherever, MD Anderson, any place. And this is a help, and it's an encouragement to the physician, and it's also a help to those patients. But you have a more technical question that I can't answer, so I'm going to let Mr. Ivers do that.
▶ Play
Thank you. I'm David Ivers with Mitchell Blackstock. We represent the Arkansas Medical Society and assisted with the drafting of the bill. Representative Meeks, I mean, we did wrestle with your question, and this was actually agreed upon between the insurance companies and the sponsors. And ultimately, and I can't speak for them, from our position, if we had put language in like that, it would have put, the reality is that there's not true negotiations from our point of view between physicians and insurers. So when you say to allow physicians to take a lesser amount, I can assure you it would be a lesser amount because there's just not equal bargaining power there. So as Senator Bledsoe said, we needed some incentive to promote the development of telemedicine and without parity and reimbursement, that's just simply, we did not feel it was going to happen. Follow-up, Mr. Chair. You're recognized for follow-up, Representative Mix.
▶ Play
How would you respond? Because if a doctor, if maybe they can do something at a central location, they would save gas money not having to drive to a remote location to see a patient because I know some doctors travel back and forth from city to city, so they're wasting gas money but they're also wasting time that they can actually be seeing the patients so they may want to take they could actually potentially make more money by taking a lesser reimbursement because they're able to stay in one place, see more patients that way instead of having to lose time traveling back and forth or am I missing
▶ Play
the sorry can you hear me yeah I think maybe there's a misunderstanding about the originating site and distance site if the patient has been seen previously and had a history and physical then they could go to a federally qualified health center where there's not a doctor but there's a health care professional nurse and they could do telemedicine with a doctor from that facility. Is that what you're asking me? At the originating site, it doesn't have to be a doctor. It can be any of those facilities in any health care provider once they've had an in-person physical by an APN or a physician. I don't think I'm
▶ Play
quite understanding but maybe through other questioning and everything I'll come back to you in a moment if that
▶ Play
works with you Representative Hammer you're recognized for a question Thank you Mr. Chair and maybe this is a tag on to his but what I'm trying to understand is one of the things that the doctors in my district tell me is that they're tired of fighting with the insurance company because the insurance companies beat them down as far as what they're going to reimburse and everything and why do we want to give greater authority to the insurance companies to decide where the money gets split to when they're currently fighting with them now. And that's one thing I need a little help understanding.
▶ Play
Well, you know, we don't want to, but that's just the way it is. In fact, having been here for quite a long time, this is the first time I've ever had the major insurance company in Arkansas on one of my bills. And so this just says, Representative Hammer, that they can't pay less than an office visit, but that doesn't mean they can't pay more. And we had to write the bill very narrowly as a first step because we needed that reimbursement to encourage physicians who would have to make that investment in the equipment. So we've done the best we can. And, again, if you would remember that this is aimed to the rural areas of Arkansas. I wouldn't need this in my area. But there are many rural areas that this will be a real help to them. Follow-up, Ms. Sheehan. Yes, sir. Okay.
▶ Play
Go ahead. The other thing is, it's like she said, we're trying to make a bill that, you know, would pass with the insurance. We don't want to increase the cost of health care. It just allows insurance to pay parity. And it also says that if insurers decide to pay beyond the limits of this bill, that it is permissive in that way as well as it's permissive with the medical board to extend further options for telemedicine. I've never known an insurance
▶ Play
company who wanted to pay more than the minimum, so that kind of catches me off guard.
▶ Play
I've never heard that before. And Representative Hammer, that's why we said they couldn't pay less than an office visit
▶ Play
because you never know. Follow-up, Mr. Chair. There's no one else's queue, so
▶ Play
let's give you another follow-up, and I'll go back to you, Representative Meeks, if you'd like. All right, thank you. We've heard in this committee meeting last week, I'm just going to be, you know, real to the point as far as Teladoc and what we've heard in their testimony. One of the things that was said from the medical, unless I'm mistaken, correct me if I'm wrong, the medical board or the medical society acknowledged that there's a shortage of doctors in Arkansas. And so can you explain for me, and you mentioned APR, and, you know, I kind of represent that side, you're representing that side, and in the middle are the citizens. So tell me how in the absence of physicians in these medically underserved area that telemedicine is directly going to impact them and where the APR ends and the doctors are
▶ Play
expected to work together in order to meet that need of our state. Well, again, you know, everyone's included. You know, we want to open up health care, good quality health care, access to specialists that sometimes only the urban areas have to the people in the rural community. Why, you know, why would we expect for the people in the rural community to have less care and less quality care than we have in the urban areas? And I believe they can work together right now that, you know, the insurance companies pays, and an insurance company that I know of pay social workers, they pay psychologists, they pay whomever they want to. And, again, this was APNs are welcome. As you know, there is that collaboration agreement at this time, but there may not be. But that's up to the insurance companies. We're just asking that they pay no less than an office visit that is split or shared with the distance site. and the originating site. They already pay, like I said, they already pay for the distant site, but they would be sharing some of that with the originating site, which would be the rural areas.
▶ Play
Representative Hamburg, because no one else is in queue and you're kind of on a good, we'll continue with you, yes, sir. Thank
▶ Play
you, Mr. Chair. So let me give you a scenario. If you've got an APRN who wants to go out into a medically underserved area in the state of Arkansas where there's not a high level of physicians providing care to that area, and that APRN has a collaborative agreement and decides to go into, say, DESARC and set up a location, and they have that collaborative agreement, then they could access telemedicine under this bill, but then the question becomes, is that APRN going to be reimbursed at the physician rate or the APRN rate, and
▶ Play
can you expound on that, please? Well, Representative Hammer, if I understood the question, the APRN will be reimbursed the same. Whatever the APRN is reimbursed today for an in-person is the same way it would work under telemedicine, but each insurance company sets the amount of the reimbursement, and that's the same way. We did not change that in the bill. so whatever the reimbursement rate set by the
▶ Play
insurance company you could have the aprn out there working under telemedicine but the reimbursement rate for that aprn who's in that area is going to be lower than if a physician is out in that area and that's all controlled by the insurance company i don't understand the question i think i understand the question we're
▶ Play
not changing what is done with insurance now however they're reimbursed this just applies if the if the APRN or the physician in a rural area wants to access a specialist through telemedicine and when they access the specialist then that fee is the fee that is split between the specialist and the originating site any other services they provide you know or just reimburse however their contract is with the insurance company now. It's not affecting any of that. This is just for the telemedicine consult.
▶ Play
So if the reimbursement rate for the physician or the APRN as directed by the insurance company under what this law is going to allow would be higher than what that APRN might have through the collaborative agreement just seeing somebody, it would almost be financially beneficial for them to access all telemedicine docs instead of the one that they have collaborative agreement under. Is that a potential scenario?
▶ Play
No, I mean that shouldn't be the case because the telemedicine visit is actually a split
▶ Play
fee. I'm not sure I understand what you're asking. Thank you Mr. Chair for the tolerance. Yes sir, it's an interesting
▶ Play
line of questions. Representative Sullivan, you're recognized. Yes, one of the watershed points seems to be the The professional relationship on page two, I guess it is, where it talks about this one-time in-person visit, and that seems to be kind of a difference between that and other bills that are out there. If this only requires a one-time visit, but it doesn't have an end date on it, so a patient could come, have this one-time visit, might go one, two, three, five, ten years out and never have to come back. It seems to devalue how important that one-time visit is, especially for the critical
▶ Play
patients that you're talking about. Mr. Chairman, we have Dr. Curtis Lowry, who started the telemedicine program at UAMS, and this was the genesis of my bill after taking the health committee last session to the telemedicine department and seeing the wonderful work being done there with the difficult pregnancies and strokes and heart attacks. And now they're using telemedicine when there's a farm accident and someone gets their hand cut off, being able to reattach it. May I call him up to answer that question? Do you think he can answer this question? I think he could. We
▶ Play
Speaker 169 58:21
would like to hear him. All right.
▶ Play
Thank you so very much. Mr. Lauer, if you could go to the end of the table and introduce
▶ Play
Speaker 174 58:34
yourself for the record, and you'll recognize to answer this question or give testimony. Thank you. I'm Dr. Curtis Lauer. I'm chairman of the OB-GYN department, and I'm director of the Angels Program, one of the largest telemedicine programs in America that's been operating over 10 years, and I'm a board member of CTEL, which is Center for Telemedicine and E-Law. I'm a board member that's in Washington. And I think one of the confusing issues that I've heard so far is that the originating site, which is where the patient is, could be anywhere in Arkansas, and there's a practitioner there. That practitioner can be an APN, it can be an MD, it can be an RN even, theoretically. And that person can say, I need help. I needed to get a consult from, for instance, a cardiologist. And in that situation, you know, they would set up a consult with a cardiologist, and that patient then would consult with the cardiologist at the request of the APN, and then the consult would be done, and then they'd be paid at the current rate of what a consult would be paid. You'd split the amount of money between the doctor doing the consult and the APRN in their clinic in the rural area, and that's how the individuals would be paid. I would expect from that point on that the primary care provider in the rural area, whether it's an MD or an APN, would continue to see that patient over time. But if that APN dropped that patient from their practice, we would expect them to be picked up by another primary licensed provider somewhere else before they could do another consult, right? So what we're doing is we're supporting practitioners in the rural area through distant technology so that they don't feel alone and the patients don't have to travel long distances to get care delivery.
▶ Play
Chair Unverified 1:00:34
Does that answer the question? Representative Sullivan, let me. Sorry, but I never heard an answer. I didn't either. I don't think that you. What you said actually almost sounds like you think there should be another visit when there's
▶ Play
needed. Well, I'm just, let me try to restate my question. In the bill, it requires a one-time visit at the doctor's office. However, there's no end date to that. So after that one-time visit, and let's say the patient doesn't have some of the serious situations. So you have a one-time visit. The patient doesn't come back to the doctor for one year, two years, three years, four years, ten years, twenty years. But that one-time visit would still suffice. that seems to devalue this necessity of a one-time visit. If I can go five years and I have a serious heart condition and I can go five years, the law doesn't tell me I have to go back. They may suggest that, but the law doesn't say that. That would seem to say that this one-time visit really doesn't have that much weight unless you have a serious issue. For example, a person that might have a head cold. that they could call back in? I just don't see the data in here.
▶ Play
Speaker 174 1:01:51
I understand your point, and the answer to that question is we're only taking referrals from primary care providers, right? They're not going to come and see the specialist over and over again without another consult for the primary care provider. It's up to them to decide how often they see that patient. You know, so, you know, there aren't many practitioners I know of that are going to refer another patient to a subspecialist without having seen the patient to know that they need to be seen again.
▶ Play
Speaker 94 1:02:25
Short follow-up. Original insight, right. Yes, sir, Mr. Sullivan. Go
▶ Play
ahead. I'm talking about not these serious issues. I'm talking about people who have less serious issues because, again, the watershed point between this bill and another bill that's out there is not over the serious issues that you're talking about. It's talking about the minor things that patients see on a day-to-day basis. I'm just wondering why at this level, again, it just devalues for these minor threshold health issues. That initial consult seems to be devalued in the bill. Thank you, Mr. Chair. Can I respond to that?
▶ Play
Well, yeah. And that's exactly why the originating site requires a health care provider or a health care facility because they're not going to, if they're required to be at a health care provider or health care facility, they're not going to be doing a telemedicine visit from anywhere else. So they're seeing their health care provider every time if they're having a telemedicine visit. And not
▶ Play
Chair Unverified 1:03:28
to throw myself in the middle of that line of questions but I'm kind of still not hearing an answer to Representative Sullivan's question. Let's take myself an example, Representative Ferguson. I don't even have a primary care physician right now how's that for the chair of health of the state of Arkansas I don't have a PCP because mine retired because of all the regulations said heck with it I'm out and I'm in a rural area and I don't have a PCP but I have let's say that I go visit one and I start my telemedicine I don't have any issues I don't have any real problems I don't need a referral to anybody I wouldn't have to go back for 20 years under this bill I wouldn't have to go back for 40 years I may never go see a doctor again if I can just call in to somebody here and call in to somebody there and get the health care that I think I need. But you
▶ Play
can't call in from home. You have to be at a health care professional or a health care facility to do the telemedicine business.
▶ Play
Chair Unverified 1:04:22
So you're saying that I'm going to see a doctor by osmosis basically because I'm going into a health care facility. I can't
▶ Play
call in from home. You have to go to a health care facility or a health care provider. If you saw your physician or your APRN and they had done a history and physical, then you could go to a health care facility, like you said, an RN or something, and see a follow-up visit, but because it's requiring a health care facility or professional to instigate the telemedicine visit, then that in itself protects from what Representative Sullivan is saying.
▶ Play
Chair Unverified 1:04:55
Much better. Okay. Representative Wardlaw I think stepped out, so we'll go back to Representative Hammer again, and we'll
▶ Play
put Representative Meeks. So could a, say, an APRN that has, could this replace the collaborative agreement arrangements if an APRN sitting out in an underserved area had a contract, I guess you'll call it, and do they have to have contracts with a telemedicine doctor, and at that point the fee is going to be split at that point, Can you elaborate on that, please? I don't think you
▶ Play
Speaker 174 1:05:41
have to. You certainly do not have to have a collaborating agreement with the consulting physician when they do the consult. You know, if they're a licensed practitioner practicing, they can originate the consult with a doctor at the referral center no matter what. So it's not only with that doctor. And all we say is they have to meet the requirements of the state of Arkansas in terms of licensing. Does
▶ Play
that answer your question? I think if Chair, allow me to carry it out a little further. One more, you bet. Thank you. In the telemedicine arena, would a physician or an APRN have to have working arrangements with each specialty offering themselves under the telemedicine arrangements? For example, you'd have to have a cardiologist. You'd have to have maybe another family practice and on down the list. Would they have to build an arsenal of physicians of specialty in order to be able to work on behalf of their patient? Or is it just one portal point and it gets divided out from there?
▶ Play
Speaker 174 1:06:55
Well, it could work probably both ways, actually. I mean, right now, if we get referrals all over from the state of Arkansas, from APNs and RNs and doctors, and we don't, I mean, the relationship is that we will work collaboratively with those guys. There's no formal contract or anything like that. But it's a relationship that we've established through this portal that we've set up in the state. Does that answer your question? There's no legal requirements that you say, Fred, will you take my patients prior to doing the telemedicine consult?
▶ Play
And what would happen under the scenario that somebody got into a practice out there? So in this scenario that somebody got into a practice out there and became really dependent upon telemedicine in order to offer better expertise to their patients that they're seeing face-to-face, is there any opportunity or chance that the telemedicine doctor would pull out of the relationship what's the safety to make sure that somebody wasn't left high and dry out there yeah it's there's
▶ Play
Speaker 174 1:07:54
no absolutely no difference in the way it works today that could happen without telemedicine it could happen with telemedicine but the the advantage of telemedicine you have access to more sub-specialists you know than just a few okay i'm gonna move on
▶ Play
Chair Unverified 1:08:08
Rep. Payton for a moment. Rep. Payton, you're recognized. Thank you Mr. Chair.
▶ Play
I'm not sure I know how to structure a question here but does this bill have anything to do with allowing an Arkansan who wishes to establish an online relationship with a health care provider to do that or are we just talking about how we're going to divvy up the money amongst the specialists and the primaries and the I thought this was a telemedicine bill that would allow the citizens of Arkansas to establish an online relationship with
▶ Play
a health care provider. Representative, I think you're exactly right. We've gotten a little off track. The bill definitely allows Arkansans to establish relationships directly with a, whether it's a physician or other health care professional through telemedicine, as long as they're all practicing within their scope of practice. There are different types of situations. There's the situation where you can have the patient at the originating site who needs to speak to a physician at a distant site, or you can have a situation where there is a physician there with the patient, but that physician needs to consult with Dr. Lowry or someone else. So we've got two different types of scenarios. Yours is addressed in the bill, and so is Dr. Lowry's situation addressed in the bill. So you've got both types, and I think that's where some of the confusion is coming from. Okay.
▶ Play
Chair Unverified 1:09:42
Thank you, Mr. Chair. Yes, sir. Representative Meeks, you're recognized for question. Thank you, Mr. Chair. And my line of questioning is going to be around the other bill that we have out there, House Bill 1747. We heard testimony last week on the Teladoc. They're operating in 48, soon to be 49 states. and there was testimony, you know, I think that the medical board, medical society or whatever was opposed because they said they couldn't find a model. It seemed like it anyways. So now we've got a bill, and I don't know how similar are these competing bills. What is the difference between the two bills and kind of would this bill allow a model like
▶ Play
Teladoc to be able to operate in the state of Arkansas? Representative Meeks, this bill is written so that it is the discretion of the Arkansas State Medical Board through its rulemaking as approved, as the chair said, by the legislature as to what constitutes a professional, the establishment, what is required to establish a professional relationship. That issue is one of several that are obstacles to Teladoc, but that's why we put the discretion in there. So as the medical board rules currently stand, the model you heard described in here last week would not be permissible. I'd just like to say
▶ Play
Speaker 174 1:11:15
one thing. I have two sons in medical school right now. One of the first things that we are taught as physicians, RNs, other licensed health care providers, how to do a physical exam on a patient. That's incredibly important. And what we do is we systematically examine organ systems in a human being looking for defects. If someone doesn't do that, you miss an opportunity for hearing heart murmurs or finding lymph nodes, which are cancer areas in the body, that would be diagnosed and then we can initiate treatment. And without doing that, it's a very huge disservice for the patient population. And that's one of the – I don't know of any medical school in America that teaches people to do physical exams over the phone. It's impossible to do that. And so that's very important. Let
▶ Play
Chair Unverified 1:12:17
me interject just a second, Representative Meeks. I'll give a little speech from the chair, and then we'll continue this. We have two bills. I mean, there's no question we have two bills running back-to-back. They're different bills. One likes one, one doesn't like the other, so on and so forth. Here's what the opportunities are for this committee. We can pass one. We can pass zero. We can pass them both. But what I want to do is I want to concentrate on this bill while it's in front of us and then the other bill when it's in front of us and not necessarily compare them through the testimony, although we can't help but do that, Representative Meeks. I get that because we are looking at both of them. And quite honestly, I mean, it's a pretty exciting place to be today. We're trying to establish the rules for setting up telemedicine in the state of Arkansas, which is exciting. It's big, and I can't call it the future of medicine by any means, but it is a way to help at least rural Arkansas. This is a big step, and I get where you're at, but I don't want to go off to where we're comparing the two bills during either bill, although we can't help but do that. If we love them both, we pass them both, you know, although with them being competing bills, it would really mess up. It would, yeah, the other one would basically, without going in both bills because I've asked these questions knowing this would come up committee if we pass this one and pass the other one these rules would basically be superseded by the other rules because the other rules are way more lax than these rules these rules are tighter so if we pass this bill than pass the other one it basically does away with the rules that this bill established and again I just said we weren't going to compare the two bills but I'm going to do it briefly This is a set of rules that's pretty strict. The other is a set of rules that's pretty loose, and that's kind of what we're going to do is figure out how we go forward with telemedicine in the state of Arkansas and figure out if we like tighter rules or loose rules or whatever it is. That's the most uneducated comparison of the two that I can possibly offer. You recognize, continue, but, again, we want to hear this and figure out if we like this set of rules or not is what we really want to do. Thank you, Mr. Chair. And along those particular lines, I'm going to admit to everybody on the committee and everybody watching at home, I don't have a primary care physician either. Usually when I'm sick or I feel bad, I'll go to the urgent care clinic there. They do a good job of taking care of me. So my question is this. In my scenario, if I decided I wanted to do an urgent care clinic, and then later on wanted to use telemedicine because, hey, I have a sinus issue, and I know it's a sinus issue, and I just want to get on the phone to my doctor, whether, and again, I think you have to go through a primary, so let's say I find a primary care physician, and then I have the same sinus issue, I call on that, can I call on the phone to that doctor for him to prescribe me some kind of medication or whatever, and I understand that you want to see the patient and everything of that nature, but it's just like with other health issues, I have to decide on whether or not I'm going to go to that urgent care clinic, my primary doctor, or if I think it's serious enough, I'm going to go to the emergency room. Will this bill allow me, if I feel that it's just a simple sinus problem, can I just get on the phone with my doctor and say, hey, doc, I've got a sinus problem. Can you prescribe me the same medication that you did before without actually having to go in and go into the clinic to see them. Sure.
▶ Play
Let me answer that. If you've established a relationship with a doctor, what you're talking about is not telemedicine. I mean, telemedicine is not a telephone call. Doctors all over the country for years have done that. They do not charge for it. My family practice doctor has a nurse that all she does all day long is sit at her desk and answer telephone calls and respond to patients' needs And sure, if your doctor has done a history and physical recently and they feel comfortable with prescribing over the telephone because they know you as a patient and they know your medical history and they know if you're diabetic and have a lot of blood pressure and what your physical situation is, that is managing care. And we certainly support that. This bill does not prevent that. That is done today. It is the driving force behind the patient-centered medical home and the primary care case management models. Those models use nurses and social workers and all kinds of people to help people access care and stay out of the emergency room and get in contact with their doctors. Almost every insurance company today requires doctors to have 24-7 coverage. That means they have relationships with doctors where they have cross-coverage to take phone calls for them and monitor things on the weekend, exactly what you're talking about. That is a telephone call. That is managing care. That is not telemedicine. Telemedicine is two-way audio-visual consultation where the doctor at the other end is treating you and the patient at the originating site has a health care provider there to help do a physical exam if needed.
▶ Play
Chair Unverified 1:17:34
My next question is probably similar to yours. and reading this definition so we wouldn't be charged for making that phone call because that's not telemedicine and that's not as defined in here. Absolutely. I mean, doctors,
▶ Play
if you have a doctor, and the biggest savings in health care, I might add, Representative Link, is if you would get a primary care physician.
▶ Play
Chair Unverified 1:17:59
First off, I have to tell you, thank you for not using acronyms through that entire speech. You did a great job. You said patient-centered medical home. You're calling a primary care physician. You're doing a great job, and you're right. I need one, and I've had one of the doctors today tell me he will be mine. I have to call him in April and
▶ Play
set up an appointment. I'm looking forward to that. And I promise you, once you've seen him, you can call on the phone, and probably half the time they will be able to make an assessment or call in an antibiotic or do something over the telephone free. But if they think they need to see you and do a throat culture or do lab work, or I've told this story, I sat near someone who had a consult over the telephone with the bill we're talking about. She had a urinary, they told her she had a urinary tract infection with no urine test and she was sitting by me, was missing the next day and I said, what happened? She said, oh, I had a kidney stone and I had to go to the emergency room. So I think it's important to have that doctor relationship that has your history and physical and knows you as a patient so they know what's appropriate. There's no way to know that if you have not seen
▶ Play
Chair Unverified 1:19:10
the patient. All right. Representative Sullivan, you're recognized. You're okay. Representative Fite, you're next in queue. Are you? You're good? Okay. Representative Fite, you're
▶ Play
recognized. Thank you, Mr. Chair. I apologize. I had to step out to another committee for a few minutes. So if you've answered this, we'll move on. I live in a very rural area. Where am I going to be when I am doing this telemedicine? Am I going to be in my home talking to the doctor over my smartphone,
▶ Play
or where am I going to be? Representative Fite, in the bill, it lists many of the places, and not all of them, but let's go back. I'm sorry, not in the bill, but it says the originating site includes physicians, clinics, nurse practitioners, pharmacy, hospitals, skilled nursing facilities, community mental health centers, on and on. You could be anywhere. You could go to a critical care facility. you recognize I'm sorry I'm
▶ Play
just failing to see how this is going to help me if I still have to go somewhere if I can't do this from my workplace or
▶ Play
from my home I'm just not understanding that's the other bill like the chair said this bill has been written in a very narrow way so that we could get support from the largest insurance company in Arkansas without reimbursement of some sort, telemedicine in the rural areas will not be viable. There is a, you do have to invest in this equipment. It is not like Skyping. It is not like FaceTime. There is an investment, and that is part of the reason that we wanted to get the support of the largest company, insurance company in Arkansas. So I can't tell you that this is going to meet all your needs. What I say is that under the medical board, they have, and like the chairman pointed out, any of the rules that they make will have to come through the committee and we'll be able to encourage them to do either more or less of what they would want to do. But under this bill, there is written in there that the medical board could change their mind. But right now, you cannot access, I mean, you could call your own family physician like we just pointed out. But this bill is written to a point where it's like going into a clinic, going to a hospital, going to an urgent care facility, going to a community health center. There are many, many places. But this bill is written that way. The other bill is written in a different way, where you can call up and access some help by telephone. But that is not this bill. Thank you.
▶ Play
All right, Representative Boyd, you're recognized for a question. Thank you. I suspect somewhere in here you've already answered this, but I want to understand for my own clarity. Would you please describe to me how
▶ Play
this works across state lines? That's a good question, and I think somebody else needs to answer that, because this is, my desire was to focus on the rural areas of Arkansas. I don't know about the other states, but I think Dr. Lowry
▶ Play
Speaker 174 1:23:06
would. Yeah, we actually have a clinic in Tulsa, Oklahoma, and so in that clinic, we had to get licensed in Oklahoma. We're working with a teaching institution in Tulsa. And so we do it meeting all the requirements of being licensed in Oklahoma. So any time you do that, you have to get licensed in the state as a practitioner. And maybe later on we'll get into all the different requirements for licensing in other states and the way the medical boards are approaching it. But we got licensed, and that's the way it would
▶ Play
Speaker 223 1:23:46
have to work. All right. Yes, sir.
▶ Play
One follow-up. So just to clarify, with this, there is a provision that would allow me, I mean, just from my perspective, I'm from Fort Smith, there is a way that we could communicate with someone from Tulsa or Missouri.
▶ Play
Speaker 174 1:24:03
If they were licensed as a practitioner, they could get on our network, and that can happen. Okay. Thank
▶ Play
you. Rep. Sam Henderson, your turn. once again I apologize I was in another committee and if you've already gone over some of this but you know we all know the need as we go forward that telemedicine is going to be just a huge part of our life can you kind of elaborate I guess a little bit on does the does the medical board support your bill as the way it
▶ Play
is this bill was written under the guidelines of the Arkansas Medical Board. Ladies and gentlemen, we are the public health committee, and when you have a board, I think it's very concerning to circumvent their rules and regulations. Again, as the chairman pointed out, we will have the ability to look at their rules and look at their regulations and encourage them to see things our way. But we need to be careful because those boards are in place to take care of the people here. They're in place to be concerned about the welfare and the safety of people in our state. And just like nursing boards or the pharmacy board, this is very concerning when people want to circumvent the rules of the medical board. But, yes, I would think that now I'm assuming that they do. In fact, I had the attorney for the medical board in my office, and he seemed fine with it. I didn't specifically say, hey, you really do support this, don't you? because it was written under their regulations. I'm not going to circumvent the medical board. I don't feel comfortable doing that. But what I did do was, again, I did place in this bill the ability for them to change their minds. They see where telemedicine is going, and they see that there are changes coming. And so in my bill, we don't have to wait until 2017. They can change their minds on some of this, but for me to circumvent what they want to do was not something that I could do in good conscience. One follow-up. One
▶ Play
follow-up, yes, sir. But they will be your governing board, so anything that comes out of this legislation will go before them. They will govern you. Yes, yes.
▶ Play
I think that they have our best interest at heart, and again, they see change coming, but they want to make sure that it's the right change, and I agree with that. And if this bill passes, again, there are things written in the bill that make it possible for them to change their minds, but it's the medical board's decision and I am very comfortable with that because of opening it up too much as I said early on if we do too much then it's going to be difficult to bring it back in we're going to move on
▶ Play
Chair Unverified 1:27:42
and members the next three have already asked quite a few questions and I don't want to stifle debate because this is a big deal as I mentioned but we've got quite a few people signing to speak for and against and so on and so forth so Representative Sullivan you recognize and let's again I don't want to stifle debate but I want to try to
▶ Play
keep it brief if we can. Yes sir. I noticed on page five in line nine it talks about this is would this program be met pardon me would the program be mandated that Medicaid pick up payments for this under the private option if we go over the limits what line are you
▶ Play
talking about I'm on page 4
▶ Play
I'm sorry page 5 I got it health benefit programs receiving state our federal goes on down there and talks about Medicaid programs so that would appear to say that if there are overages in this program that the state would have to pick those up is that correct and if so would that require a fiscal impact study Representative Sullivan, it's
▶ Play
only what, it's the same way as with the private insurers that Medicaid would only have to cover a physician service if it's covered in person and that they do not have to pay any more than they pay today. And actually Medicaid covers more services under telemedicine today than are in our bill. All right. Was that it, Representative Sullivan? Good. Representative Hammer? I want
▶ Play
Chair Unverified 1:29:17
to ask him a question. I want to ask the
▶ Play
chair a question. I'll be quick. Sure. In the process that if this bill goes through, then in the interim before the next general session, any changes or modifications would be initiated on behalf from the medical board and come through under the Amendment 1 process through the legislative process for approval. Is that correct? That's correct. It would first be heard by this
▶ Play
Chair Unverified 1:29:50
very committee, the Health Committee, during interim, and then it would go to the Rules and Regs subcommittee of the council and then go through council itself. It would actually go through three
▶ Play
processes of this body. Okay. That's if they initiate it. What if a member of the legislative body wants to initiate something?
▶ Play
Chair Unverified 1:30:08
We cannot impose rules during the interim. We can review rules. We cannot impose them. So the servant is... That's why we
▶ Play
have to act during times we're in session. Right. But what we're going to do, though, is we're getting the impression that things can come back around, but it's going to be initiated on the medical board side. Yes, sir. But if we have something that we want to initiate as we see it develop, the only way we could do that is to convince the medical board that this is something that really needs to be put on the table for discussion to come from them. So as far as circumventing, we are going to be circumvented by that process and that we're not able to initiate anything unless we can convince the medical board of it. Is that a fair? I wouldn't
▶ Play
Chair Unverified 1:30:50
call it circumventing, no, because that would make it sound like they're going around us. Instead, they have to go right through us. Okay. All right. Thank you. All right. Representative Meeks, you're recognized. Thank you, Madam Chair. Senator Bledsoe or Representative Ferguson have you been in contact with any of the big companies like Tyson, J.B. Hunt who would use these telemedicine services we already know that they're in support of the other bill because it will allow them to do what they want to do with their employees have they given you any feedback that
▶ Play
this is going to allow them to do to provide their employees with that option? The answer to your question is just remember where I live I live in northwest Arkansas. You're talking about the people in my area. I have talked to J.B. Hunt, the head of their Employees Benefit Division, and he has some concerns that my bill would not possibly allow what he wants to do. But there again, because of those concerns and even because of Teladot, we wrote into this bill that the medical board could change its mind. Here's what's happened, and this is my opinion. One of these companies came in, and to my knowledge, they did not consult with the medical board. Someone complained. The medical board didn't know that they were here. Someone complained. And then they rescinded their services. And so it's been kind of a fight between those type companies and the medical board. And again, ladies and gentlemen, if I have to make a mistake, I want to make it on the side of protecting people, and I think that's what they're doing. But in this, because of those concerns in this bill, and I do believe, I can't prove it, but I do believe the medical board is getting the message that they're going to have to do something, and I believe that they will do something, and that's why I put that in there, so that they could come to some kind of agreement, and it would be a process. I'm sure just they're not going to overnight say, you've got carte blanche. You can go ahead and do these things, but there will be a process where they can allow, and, again, companies in my area like J.B. Hunt and others to accommodate them in a short period of time. But I cannot prove that, but I do believe that will happen, and my bill will allow that to happen. Okay. Thank you, Mr. Chair.
▶ Play
Chair Unverified 1:33:35
Yes, sir. All right. We're going to move on. Mr. Ivers is at the table. He's four, but we're going to move on to some against testimony. Mr. Justin Allen, if you come to the end of the table, you're recognized to give testimony against this bill. Of course, introduce yourself for the record. Yes, sir. Thank you, Mr. Chairman.
▶ Play
My name is Justin Allen. I'm an attorney here in Little Rock, and I'm speaking today on behalf of my client, Teladoc Inc. This committee, for those of you who were present last week, heard testimony on House Bill 1747. It's back on the agenda again today. I'm not going to speak to any of the substantive quality of care standard of care issues I know we hear a lot around here I'm not a lawyer but I am a lawyer but I'm not a doctor so I'm not going to be getting into those issues but I want to speak to the fundamental concerns that Teladoc and its proponents have with Senate Bill 133 I first want to thank Senator Bledsoe and Representative Ferguson for the time that they have given to me and my client over the course of the last two or three months frankly to talk at length about this. Unfortunately, we haven't been able to see eye to eye on exactly how this should move forward. And the one change that Senator Bledsoe did make to the bill that she's referenced several times is helpful, and that is in the manner in which the physician-patient relationship is formed. It was amended such that the medical board is left with some discretion in determining how that's done and whether ultimately it could be done, be formed via telemedicine. We are concerned and skeptical that the medical board will move as fast as this state should on that, but unless and until it does or unless and until House Bill 1747 is adopted, primary care telemedicine will not exist in Arkansas. And, again, that's probably something more for the discussion of House Bill 1747. But there are two other provisions in Senate Bill 133 that will not be left to the discretion of the Medical Board that will continue to preclude telemedicine for primary care purposes in Arkansas. One is the originating site. The originating site is going to require the patient to be at a doctor's office or in the physical presence of a doctor or a medical care provider. That is going to preclude traditional telemedicine because if you can go see a doctor, you don't need telemedicine. If you have access to that primary care physician, that specialist, or that APRN, you don't need telemedicine. You can go see your doctor, and they can check on your fever, your runny nose, and prescribe accordingly. So that will not be in the medical board's discretion. Their hands will be tied in that regard. The other part is in defining telemedicine, it excludes interactive audio. Now, I know there's questions and concerns, And, again, there's another physician here on behalf of Teladoc today to speak the House Bill 1747, and he can get into your substantive concerns about using telephone or interactive audio. But that's how most of the people across the country use traditional primary care telemedicine, is the telephone. And this bill would prohibit that, and the medical board has absolutely no discretion to change that unless and until the legislature acts again. Those are our concerns with this bill. Now, the issue has been raised and the chairman has noted competing bills, and maybe that's the case. Maybe that's not the case, and I'm certainly not going to speak for the sponsors, but the issue was discussed on the Senate committee that Senate Bill 133 is a parity bill, and it defines telemedicine for purposes of when a third-party payer is going to be required to pay for that telemedicine. And I think that there's a possibility, ultimately a court would have to decide, that a court could read these two bills if they became acts in unison such that they don't conflict, one being Senate Bill 133. These are the circumstances under which telemedicine must be provided and payment is required. House Bill 1747, this is a manner in which you can practice telemedicine in Arkansas, but a third-party payer is not going to be required to pay for it. What's a court going to say on that? I don't know. But that's a possibility, but it's not a question that I could definitively answer today. I think that it's been noted the mandate portion of the bill is improperly a concern for this committee. And then also one other point that I would note is that, and I don't know if this is going to matter, I know Representative Hammer was asking about it, and that is the mandatory payment provision. It only applies to a physician. There's not going to be mandatory payment applied to other health care providers. It doesn't prohibit it, but the only mandatory coverage here is for physicians, as I really read the language of this bill. So having said all of that, stating the concerns, the limitations, we think this bill should go further. But if this committee sees fit to pass this bill to try and address parity issues, that makes it that much more important that House Bill 1747 be adopted as well. But, again, the merits of that I will leave until that bill is presented, and I will let the medical professionals speak to that. Thank you, Mr. Chairman. Thank you,
▶ Play
Chair Unverified 1:38:49
Mr. Allen. Would you take a question or two? Yes, sir. Representative Payton, you're recognized.
▶ Play
Thank you, Mr. Chair. Assuming the other bill did not exist, would your client oppose this bill? Yes, we would. Thank
▶ Play
Chair Unverified 1:39:03
you. Thank you, Mr. Chair. Yes, sir. That's it. Thank you. Thank you. All right. For the bill is Mr. Austin Gaines.
▶ Play
Speaker 246 1:39:15
Introduce yourself, and you're recognized to give testimony, sir. Good morning, Mr. Chairman. I'm Austin Gaines. I work for the Sisters of Mercy Health System. We have seven hospitals in Arkansas. Five of them are rural critical access hospitals in Ozark, Paris, Waldron, Berryville, and Boonville. And I wanted to make four quick points. and not duplicate any of the testimony. This does help access, it will help access in the rural areas from an important perspective to us as citizens of these small areas. There's a lot of resistance to return visits to physicians in Little Rock or Fort Smith. Transportation is an issue and family support is an issue. We believe that the initial consultant visit, specialist visit, needs to be made in person. And our physicians believe that as well. And we have a major investment in telemedicine. We have physicians in St. Louis and in Tulsa who are licensed in Arkansas. And they support Arkansas-based physicians, but they come here and get a license. And we could accelerate our volume and revenue if we did not have the professional relationship established for our Mercy doctors in St. Louis or Springfield to consult. But our physicians want that physical and history and medication review and the home environment discussion to be made with the patient. and that is a limiting factor to total flexibility but it's one that the professionals agree at this stage of the game with an unknown patient is an important step this is fair to the referring physician because the referring physician gets his patient or her patient back and when a when a person is referred to a medical center it's easy for that patient to stay in the care of a referred-to physician and this allows that patient to stay at home where they prefer to stay and get to specific services and both physicians get paid I think this is a safe expansion of access because of continuity of care what one of the things that happens through this with an established relationship is that chronic disease are managed in a more quality concerned way because that annual revisit can be done by telemedicine. And we provide no charge clinics where the patient has no obligation but to walk in the door and they will not come back because they don't have a ride or they can't get off work. So the barrier of transportation and distances is larger than you might think. I think the last, yes, sir, I just wanted to make one last point. We believe the fit with the State Medical Board is important. I go to the State Medical Board, it's an important agency in consumer protection and in professional quality of the medical community, and I think they should be a part of the overall tapestry of how we deliver medicine in Arkansas, and a statute that went around the Medical Board probably would never happen, but from our perspective as a hospital and a physician
▶ Play
Chair Unverified 1:43:02
company, we don't think that's a good idea. All right. Seeing, I
▶ Play
do see a question from Representative Hammer. Okay. Thank you. Currently, are you able, are you currently offering some form of
▶ Play
Speaker 246 1:43:19
telemedicine now among your hospitals and affiliates? Yes, sir. We have two versions. One is our intensive care patients are monitored by intensivists in St. Louis. These intensivists are board-certified intensivists, and in Fort Smith, we only have two, and they can't cover two hospitals 24-7. So those doctors are licensed in Arkansas. And the second way, we have e-visits for our established patients of our Mercy clinics. And the physicians don't all participate in e-visits, but an established patient can get online and request a visit with the physician, and it's a $35 cash payment. Okay, and so this bill is going
▶ Play
to allow you to enhance what you currently have by virtue of the fact that you're going to be able to get reimbursed at a greater level. level. Is that a fair
▶ Play
Speaker 246 1:44:12
statement? Well, we don't get reimbursed at all for that intensive care service, and we won't under this. What this will do is give us more continuity of care, and the medical community is migrating towards accepting total care risk, total outcome risk, and having these improved access points so that a person gets their needed follow-up visits is really important. I think the compensation is much less of an issue to us than it is having the ability to use these tools we already have. Mr. Chair, I'd
▶ Play
like to ask the sponsor of the bill a question at the appropriate time based on testimony given a minute ago when the Chair allows, please. She'll probably allow that when she closes. That'd
▶ Play
Chair Unverified 1:44:59
be great. All right. Thanks, sir. Thanks, Mr. Gaines. and we're going to call Mr. Bill Phillips, the last one, signed up to speak against this. Thank you, Mr. Chairman.
▶ Play
My name is Bill Phillips, represent Teladoc. I'm here to speak against the bill, not because the bill doesn't have merit. It has great merit. But what this bill defines is specialty telemedicine, where another bill that you'll hear later is primary care, telemedicine. You cannot define telemedicine as this bill does statewide whenever it's dealing with specialty care. And Mr. Payton has stepped out, but he asked a question a while ago, can I pick up the phone and call a telemedicine doctor and get coverage? Where under this bill, the answer is no, unless you're sitting in your doctor's office. The originating site is what destroys the next bill that y'all will hear. Also, it leaves it totally in the hands of the medical board. We have for a year and a half attempted to meet with the medical board. We have been turned down at every turn. They will not listen to it. They do not like telemedicine. they said go to the legislature so that's what we've had to do but I think in summation against the bill first of all if the largest insurance company in the state of Arkansas has no problem with this bill if they agree with this bill with the concept of this bill then why do we have to have the bill if they don't want to be embarrassed for all these services, that would be fine. Let them go ahead and reimburse and leave this out. But whenever you go into the process of defining telemedicine and using a specialty care, and it's a great program. It's a wonderful program. I applaud Dr. Lowry and UMS for putting it together. But that's a very, very, very specialty type program of telemedicine. And to define telemedicine because one program uses high-tech telemedicine technology, it's really a shame for all the businesses in Arkansas that don't have an opportunity to use telemedicine for their colds and flus and sinus. It does not repeal or do away with quality of care. We've got 12 million people covered nationally. we have never had a patient complain to a medical board in the last 60 days there have been 7 doctor complaints to the medical board 4 of them lost their license so to say that you lose quality isn't necessary so I hope we tried to amend the bill to where it takes out the originating site because that kills true telemedicine. It is great for specialty telemedicine, but it kills true telemedicine or primary care telemedicine. And since the board told us to come get our fix at the legislature, that's what we're trying to do. This would impede that, possibly even destroy that opportunity. All right. Thank you, Mr. Phillips.
▶ Play
Chair Unverified 1:48:43
I see no questions for you, so we appreciate your testimony. Senator Bledsoe, you're recognized closed for your bill. And if you want to take a question, let me know, and I know that Representative Hammer has one. I'm sorry. Did you bring me back to the table? I did. I brought you back to close, and I asked if you... It's typical not to take questions during closing, but if you
▶ Play
would like to, I know Representative Hammer has questions. Well, let me ask you this. Could Mr. Ivers respond to what has been said today in the discussion against the bill? Well, I'm hoping that you can.
▶ Play
Chair Unverified 1:49:27
Well, I thought, anyway, so you're saying no. Well, I mean, I don't want to hear a ton more testimony. I'd kind of like for you to close. But, I mean, fine. We'll recognize Mr. Ivers for
▶ Play
a very short term. All right. And instead of taking a question, maybe you would just allow him to respond to something because that would be, I think it would be clarifying to the people on the committee. Thank you, sir. Yes, sir. Yes, ma'am.
▶ Play
Thank you. I just want to address just a couple points quickly. I do not understand the whole specialty telemedicine versus primary telemedicine discussion in Mr. Phillips' testimony. Absolutely nowhere in Senate Bill 133 is there such a distinction. Senate Bill 133, as I told Representative Payton, definitely allows for primary care telemedicine. That is just simply not true. As far as the originating site destroying the Teladot model, I'm just going to have to say, in reviewing the landscape here, there's four principal safeguards. One of them is the in-person primary, prior in-person exam, which we've been discussing here today. Some states have a follow-up required for telemedicine. Some states say that the patient must be in an originating site that has at least some sort of medical setting to it or a telepresenter. And then others make sure that you at least have audiovisual communication and not telephone only. This bill has three of those safeguards with the option for the medical board to modify some, but the other bill has none of them, none. So we have put in this bill three chief principal safeguards for the state's very first telemedicine statute. All right. May I
▶ Play
close? Yes, please. All right. Ladies and gentlemen of the committee, I appreciate your indulgence. This bill is a very difficult thing to wrap your arms around. Telemedicine is exploding. Just like I mentioned, it's exploding, but the legislation is far behind. And my bill is not about Teladoc. My bill has nothing. And when I was writing this bill, I was so surprised when I filed it and was just, you know, minding my own business. All of a sudden, there was someone saying, hey, your bill is about not allowing Teladoc to do what Teladoc wants to do. Well, I had nothing to do with that. In this bill, I've tried to amend so that if the medical board and Teladoc can get together, there is a way to expand the services under and with the approval of the medical board. That fight should not be with me and my bill. That fight should be with the medical board. You can decide that when you hear the next bill, whether you like it or not. your vote today should not have anything to do with the next bill. And this bill works, and this bill will expand telemedicine the right way in the rural areas to say that it is some way prohibitive when it comes to rural health care. the family practice physician or the nurse practitioner or whomever is not correct. And as far as paying the physician and only the physician, the largest insurance company in Arkansas already pays a psychologist. They pay social workers. I don't know who all they pay. But this was just to give parity with that office visit. And I checked. Now, I know some of you probably know better than I, because I'm kind of like the chairman, I haven't been to see a family practitioner in a long time, but I did check. Some charge $100 for an office visit, some a little bit more, so I don't know what it is like in your area, but it was just to say to those family practitioners when you make an investment in that expensive equipment that there is going to be a little bit of a reimbursement. That's all that says. And this bill, this is a good bill that works within the bounds of the medical board, and I believe it's good patient care. But the legislature, ladies and gentlemen, has never dictated to the medical board how to define a proper physician-patient relationship, and we respect their authority. If we don't, then when the nursing board comes, when the pharmacy board comes, when any of the other boards come, we may have a problem with them. And like the chairman said, we will have some input into their rules in the future. But again, right now, the medical board could expand the decision of the professional relationship without coming back. However, we also recognize, like I said, the board's current rules that may change over time. So again, that language is on page 3, lines 7 through 9. Changes are expected. This is telemedicine, and I believe it is the future of health care. If some companies want to allow for patients to be seen through telemedicine at home, and they have met the requirements for a professional relationship and remember, this is only the one-time face-to-face visit with the health care provider, then the bill does not prohibit that. It simply does not require insurance to pay for all those other models. If other business models don't fit within these parameters, this bill does not prohibit their operation. They will have to satisfy the rules for professional relationships, but again, ladies and gentlemen, that is between the medical board and those people. That is not what I'm doing here. This bill simply defines what services qualify as telemedicine and therefore whether an insurance carrier will have to be reimbursed for those services. And with that, I thank you very
▶ Play
much for, oh, go ahead, I'm sorry. I think what she's trying to say is we don't have a dog in their fight and we'd appreciate a good vote
▶ Play
Chair Unverified 1:56:30
for our bill. All right, thank you very much, ladies and gentlemen of the committee. Members, fair an explanation of the bill. Senator Bledsoe is closed for the bill. What's the will of this committee? Representative Boyd, do you have a motion? Representative Boyd has a motion. Do pass. Any discussion of that motion? I'm kind of surprised. All right, well, I'll not discuss it then. All in favor say aye. Aye. All opposed? No. Chair rules and ayes have it. Thank you very much. Thank you, committee. Representative Sullivan, are you recognized?
▶ Play
Thank you, Mr. Chair. I have a few people here to speak for the bill, to help explain the bill, if you don't mind. If they're here to
▶ Play
Chair Unverified 1:57:35
help explain it, that's great. We'd like them to be there. Thank you. Now, keep in mind, Representative Sullivan, you kind of had about an hour and ten minutes the other day to explain it, so we don't really need to hear all of it again. I think we've got a pretty good gist of it, but, I mean, you know, as I mentioned, this is a pretty serious debate and pretty serious subject. We want to hear good debate, but, like I said, we've heard you for
▶ Play
Speaker 167 1:57:59
an hour and ten minutes, but, so, we've got an idea. You didn't sound like you enjoyed that a whole lot, but that's all right.
▶ Play
I appreciate the opportunity, Mr. Chair. It was delightful, really. We'll be as quick as we can. Yes, sir. Thank you. Folks, this bill is really about access to care and whether the patients have an opportunity to choose and make some of the choices that govern their health care. You talked about some of our members who don't even have a PCP, and this would allow some of that better access in those rural areas for our patients to make those choices as to whom they'd like to see. And that's my opening statement, and I'll turn it over to one of our providers here. Good morning, Mr. Chairman.
▶ Play
Speaker 262 1:58:51
Members of the committee, thank you so much. I'm Tim Howard. I'm a family practitioner, and I'm also a consultant with Teladoc and senior medical director. But I'm a practicing physician in Huntsville, Alabama. And one of the things, just to give you a brief context, is I discovered Teladoc about six years ago. I knew nothing about telemedicine, but I had four kids in five years who were getting ready to go to college, and I was looking at trying to pay bills for college and some alternatives. So I looked through and did due diligence on this company as I received some information and found out that ethically they are of the highest standard. And after doing all the research, I realized that what I had done for 20 years, as someone had mentioned earlier, being on call was essentially what I was going to be doing with Teladoc, but it was enhanced to where I would have the medical history in front of me because each patient, before they even access our network, network has to have, as I call it, an electronic clipboard. Much as you're in your physician's office the first time and you fill out your clipboard, you had to do this online before you can even access a physician. Because of the desire for the patient and our members to pursue this, they had the choice, and they have the choice in our model of doing audiovisual, audio alone or a combination of those with the physician. We do not establish any relationship with the patient. That is our philosophy because our desire is we want to be a bridge and you've mentioned it several times this morning. Accessibility is a great issue in the state of Alabama. I know it is in Arkansas. We have the same kind of landscape, a lot of rural areas and so to to have the accessibility in some of these rural areas has been very very difficult. Along with that we may have patients that, excuse me, physicians that are accessible but not available and you may have a simple non-complicated problem come up and the physician can't see you for one to two weeks. Well by then it's either going to take you to an emergency room or it's going to resolve on its own. So the third part is affordability. And unfortunately, because we did not have the accessibility availability, patients were going more and more to emergency rooms for non-emergent simple care. This drove up health care costs, and I will speak for the state of Alabama, because it did. And because Teladoc was able to present to our state medical board, our model, our ethical standards. We are the only telehealth or excuse me, telemedicine group that practices in the state of Alabama per the state medical board. And as someone mentioned earlier about the largest health care carrier insurance in the state of Arkansas, the largest insurance carrier in the state of Alabama uses Teladoc as one of their health care benefits. So we have that with our state. This House Bill 1747 would provide that cost-effective care. Understand that the visits for our patients are $40 fixed cost. We're very fortunate that industry and insurance benefits offer that, and they will actually subsidize that up to, and even up to the full $40. Another great benefit, and as a physician, my heart is to care for patients. So one of the great benefits of our service is we provide Teladoc to Medicaid patients throughout the nation. I actually do not know who I'm speaking with, their contract or anything like that. I know that there's someone who needs care. And unfortunately, because reimbursement is very difficult in this population, in a private practice setting, which is my setting for 20 years, it's very difficult to carry very many Medicaid patients and stay in business. So this gives us opportunity to have access to patients to get quality care without compromising that, just as I could be speaking to someone who has very limited financial issues or I could be speaking to someone who's a COO of a company that we represent and that we have as a sponsored benefit. Please also understand that all of our patients are sponsored by either industry or with insurance, and there is no direct-to-consumer with our model. The patients have to be sponsored by either of those when they come to us for a consultation. Please also understand that we handle simple, non-complicated issues. Our physicians are on average 15 to 20 years in practice, and we are emergency room physicians, internal medicine physicians, we are family practice physicians, and we are pediatricians. Those are the four specialties that are represented by our group. And understand that with 15 years, 15 to 20 years average experience, we understand patient care. And we have had plenty of time in bricks and mortar to be able to do plenty of physical exams. But we've also taken call many times, and we understand what goes on in that as well. We continually, and again, my heart is to take care of patients. We continually encourage our patients to seek out a primary care physician, and that is on our hearts. So we do not want patients to establish any relationship with our group. Part of my responsibility is oversight to that with our quality assurance is to monitor if patients want to use our service more than is reasonable. And so we monitor that on a case-by-case basis in every patient that we take care of. We have secure HIPAA-compliant use of technologies, and I mentioned to you that we do want to reduce cost. We find that industry and the insurance industry has been very pleased with how much savings they have and still have quality of care. And again, with board-certified physicians, are the only providers with our service. When I began with Teladoc doing consultations six years ago, we had about 400,000 members nationwide. Today, we're between, as mentioned earlier, 11 to 13 million members. So you have said it well that it is growing, and we see that this is just the tip of the iceberg. Please understand also we have over 100 evidence-based guidelines that we use, which are based on our academies, on the AMA, on the CDC, that actually go through all the diagnoses that we treat. And we're able to pull that down in a drop-down box any time we talk to a patient to know how to properly take care of patients based on those guidelines. and as you'd mentioned as well with us being available in 48 states you'd also mentioned about technology and the timing of things I appreciate the opportunity with this bill as you're trying to get ahead of that and respond to what you see is just exploding technology. So thank you. Finally, as I mentioned, in the state of Alabama, we have the privilege of being the only telehealth provider, telemedicine provider in the state of Alabama because of our ethical nature of our company. So I thank you for the opportunity to speak today, and I hope you will speak in favor of House Bill 1747, and I'll be happy to answer any questions. Representative Sullivan, are you
▶ Play
Chair Unverified 2:07:46
ready for questions? Alright, Representative Love, you're recognized.
▶ Play
Thank you, Mr. Chair. Doc, I see that you have been here through all the testimony. I want to ask you a few questions. Number one, what What would it take for Teladoc to be
▶ Play
Speaker 262 2:08:09
in compliance with the bill that was previously presented? The difficulty with the bill presented before, and Representative Solon, if you'll help me out with that as well, is the accessibility. Part of our model is that the patient's choice is critical. If they're not, they're in a rural area, they're not accessible or available to their physician, so they physically can't get to a physician's office, they're able to access our service. Go ahead. Representative Hammer, you're recognized. Thank you. Could
▶ Play
you tell me about if I'm utilizing your service and I call in, do I get the same physician each time for continuity of care, or how is that addressed and what's the
▶ Play
Speaker 262 2:09:06
comfort level on that? That's a doctor. Thank you for that question. Our philosophy is the primary care physician is the most important relationship that a patient has. And so because of that, philosophically, we do not establish a relationship with the patient, and that's purposeful. we know that some of the other companies will have pictures of their physicians on there. You can pick your physician. You can do those kind of things. And as you know, marketing, the ones that have the best pictures are typically the ones that get access the most. So we do not have a list of our physicians on there. We do have the credentials, as I mentioned, the experience, and that we are board certified. But, again, we want the patient, and I'm telling patients this all the time, and I still take consults every day, that we want the patient to establish with their primary care physician, and
▶ Play
Speaker 260 2:10:03
we are merely a bridge to that
▶ Play
care. And when it comes to prescribing medications like anything between the Schedule 2 and Schedule 5, can you tell me how
▶ Play
Speaker 262 2:10:15
that process works? Thank you. That's a great question. We do not prescribe any controlled substance, period. We do not control any lifestyle medications such as your medications like Viagra, those kind of things. We do not do any emergency contraception or anything like that as well. And then
▶ Play
one last question, if I may. Mr. Hammer, may I just add one more thing on that just to kind of follow up? And committee members, this is a critically important point. Right now, Arkansas Medicaid allows the initial psychiatric visit via telehealth. Now, hear that again. Right now, Medicaid under code 90792HA-U1 allows telehealth to do the initial client visit via telehealth. They also allow the psychiatrist to prescribe psychotropic meds via telehealth. So at issue here, some of this talk about this initial visit and how important this is to have that initial visit, it's already being done by a psychiatrist. So I hope that answers your question about what meds can be prescribed. This group may not be able to. They're going to be referring to others. But it's already the current practice in Arkansas, and the medical board has deemed it allowable to have a psychiatric visit,
▶ Play
initial visit via telehealth. Thank you. One last question, please. Mr. Sam Hamill, I'll give you one more. We've got lots of people to get through. Thank you. It seems to me there's some tension between you and the medical board or this concept and the last bill we heard and the medical board. And if I'm understanding things correctly, the medical board is the gatekeeper for you to be able to get to where you can practice in Arkansas. So would you just identify what's the most problematic issue that needs to be resolved and how are we going to be able to
▶ Play
Speaker 273 2:12:13
address it through this bill? Claudia Tucker, Vice President of Government Affairs for Teladoc, and I would be glad to answer that. Really two things, this originating site requirement and also the initial in-person requirement. I live in rural Virginia, and so I'm about 40 miles from a physician. That's the case for a lot of people here in Arkansas. If you can get up, get in your car when you've got the flu or bronchitis or upper respiratory and drive to one of these sites, you could just as well drive to your doctor. And so for specialty care, that's a good idea, and I understand that. For primary care and for what we're talking about here, it makes absolutely no sense. The other thing is the in-person requirement. Again, for specialty, it makes sense for what we're dealing with, the non-emergent care, non-emergent illnesses, it does not make any sense. If you're a mother with three children, two of them have been sick with the flu, the third one comes down on Friday night, why do you want to drive to a pharmacy or drive somewhere else when you could just pick up the phone or do an audiovisual with your physician?
▶ Play
Chair Unverified 2:13:15
Did that answer your question? All right. Moving on, we have people signed up. Are you done for now, Representative Sullivan? I'm out of questions. Yes, Mr. Chair. Thank you. Okay. I'm going to move on to Mr. David Ivers, who is signed to speak against this bill. Thank you. Thank you.
▶ Play
Thank you, Mr. Chairman and committee members. Again, David Ivers speaking, representing the Medical Society, speaking against the bill for several reasons, and it has nothing to do with the ethics or qualifications of the Teladoc physicians. They've certainly made a good case in that regard, and we're not taking issues with that. What we've heard a lot about are the free market benefits of this bill, the consumer choice. But first and foremost, please remember that the chief concern has to be patient safety when you're talking about medical care. And as I mentioned, when you look at the statute, and this is a very, very fast-moving area. I mean, everything is changing very quickly. But when you look at the legal safeguards in place in the various states, it's not that it has to be in person, that that's the best way to do an initial in-person exam, but there needs to be some kind of safeguards to protect the patients when you're dealing with telemedicine. And just in my review, I noticed that there were four chief provisions, And that was one example is the in-person exam or prior physician-patient relationship be established. A second one in a few states is if you don't do that, you've got to at least do a follow-up exam in person. In many states, there is a third one, and that is what we're talking about. The originating site must be some kind of medical setting or a medical, what they call a telepresenter. Now, I want to be clear, in Senate Bill 133 that you just passed, it does not have to be a physician's office. And in most of these other states, it does not have to be a physician's office. It just needs to be someplace that has a professional, a health care professional present with the patient. And, you know, it could be any kind of certified or licensed professional in that case. And then the fourth one, and this is a big one, that is the definition of telemedicine and that is it is not the norm to define telemedicine as audio only or telephone. There are a few states, but by and large that is not acceptable at least for the establishment of the relationship. Now, yes, as Representative Ferguson testified, many doctors have for years, telephones have been around for over 100 years, have talked to their patients by telephone. But that is not telemedicine. And it can continue to proceed in that manner. You can always talk to your patient by telephone. But to have never laid eyes on the patient without any of these safeguards is the issue. So as I pointed out, Senate Bill 133 that you do pass had three out of four of those safeguards. House Bill 1747 has none. The most glaring example is that telephone issue. And I just want to give you just a couple examples of surrounding states. Oklahoma, telemedicine is not a consultation provided by telephone or facsimile. Tennessee, telehealth does not include an audio-only conversation. Mississippi, telemedicine must be real-time consultation. It does not include the use of audio-only telephone. Louisiana, two-way video and audio transmission simultaneously. Texas, requires the use of advanced telecommunication technology that allows a distant site provider to see and hear the patient in real time. So, and with that, I would like, if you could, for you all to look at the map that's in your packet. It's this, the color map of the states. And let me just say in full disclosure, as I said, there's over 100 bills that have been introduced in this first couple months of the year already in 36 states. So this, you know, this changes every day. So right off the bat, I'm going to tell you that California and Colorado have switched, that California would be a green, and I'll explain the colors, and Colorado has a bill sitting on the desk for the governor that will change it to a red. So the numbers stay the same, but two states switch. Okay, under the bill that we're looking at now, House Bill 1747, what this map shows you, You've heard the testimony that the operations of Teladoc, as reflected in the bill, are permissible in all but Arkansas and perhaps Idaho. Let me just say, when you start looking at it, and these are just the states that we were able to find quickly, in at least 21 states that the operations of Teladoc, as reflected in their bill, would not be permissible. And those are the states in red. Two states are in dispute, and that is North Dakota, which issued a cease and desist order against Teladoc, and Texas, their home state, where they are involved in litigation with Texas about what they can and can't do. Many legislatures are just now starting to address telemedicine through the states. Most states have never comprehended that a simple telephone would suffice for telemedicine from beginning to end, at least not with a health care professional at some point, some place, originating or distant site, laying eyes on the patient. And when you say that you're operating in all of these states, when someone says that, we've got to be careful because Teladoc was operating in Arkansas until the medical board got a complaint and threatened to pull the license of a doctor. In Texas, they were fully operational until that lawsuit occurred. In Idaho, they were operating until a competitor of Teladoc, a doctor, was threatened with sanctions there. In North Dakota, they were operational until the cease and desist order was issued there. So many legislatures are working through these bills, And what I think we're going to see is that some states that are in green don't have any law at present, but they will, it looks like very soon, have laws. And I predict that many of them will turn to red because especially on that telephone-only issue is a very important concern. So with that, I am open to any questions. Representative Wardlaw, are you recognized? Motion, please.
▶ Play
Chair Unverified 2:21:01
And what's your motion? Limit debate to five minutes on either side. Representative Wardlaw, considering seriousness of this number of people, I think that five minutes might be very
▶ Play
Speaker 277 2:21:22
short. Fifteen. so your motion is
▶ Play
Chair Unverified 2:21:24
10 minutes per side which will give us 20 minutes to give us done give us 10 minutes to hear two more bills okay I'll accept that motion it's non-debatable all in favor say aye any opposed no I said no's have it we're all right question uh question representative Mix. Yes, Mr. Chair. My question is this right here because apparently it was one complaint and you can correct me if I'm wrong. One complaint and we basically shut Teladoc down which had you know 7,000 folks using it or whatever the case may be. I mean do we hold the same standard with other things as well? Like if you get a one complaint against a doctor in a physical location Are you going to shut that doctor down? I'm having problems understanding why Teladoc, it was working. You had one complaint, and now all of a sudden
▶ Play
it's a bad model. It's not working anymore. Representative Mix, I don't think it's not the fact that there was one complaint. It's the fact that the medical boards did not know until they received a complaint what Teladoc or one of its competitors were doing, And once they found out, then that was the means by which Teladoc or its competitor was no longer allowed to operate was because that was brought to the board's attention. They send letters out and say that what you are doing is not legal, not just for that one physician whose credentials are going to be sanctioned, but for any physician. Follow-up, Mr. Chair?
▶ Play
Chair Unverified 2:23:08
So my question is this, because this is not just some small operation. This was being used by some pretty significant companies here in Arkansas. And you didn't know that Teladoc, what they were doing, the medical board had no idea that they were doing this in the model that they were using. Until that complaint, I'm sorry,
▶ Play
but I find it hard to believe. Let me just say I'm representing the medical side of the medical board, but what happened was this is not something that happened overnight. As my understanding, in 2012, it came to their attention, and again, this is a very, as far as the Teladot model, it was new to the medical board and brought to their attention. So, no, they did not know. They might know that there's a company called Teladot, but they don't know that Teladot does not require an in-person exam or that Teladot does not require audiovisual or that Teladot does not require a telepresenter. They don't know all the facts. They might know the company is here. Go ahead. I
▶ Play
Chair Unverified 2:24:18
mean, why not? If this was concerning doctors, wouldn't the medical society approach the doc and ask them, okay, what's your business model? What are you doing? What do you require? I mean, again, I'm finding it hard to believe that you really didn't know how they operated and what they were
▶ Play
doing and everything of that nature. Well, again, that's the medical board, and they act, you know, they have a very small staff, and they act upon complaints that are brought to their attention, and I don't know how else to say that.
▶ Play
Speaker 283 2:24:51
Okay, thank you, Mr. Chair. Representative Hammer.
▶ Play
Part of what I'm trying to get my mind around is the consumer, we're going to dictate to the consumer and eliminate the consumer from having an option that while there are some ongoing debates in other states, that we are going to eliminate the citizens of Arkansas from being able to take advantage of that if that's what they want to do, which is their individual right to choose. I mean, personally, I've got a face-to-face with my physician, you know, and I'm comfortable with that. I'm just struggling with why are we going to prohibit those of which there's, I know there's 70,000 in the state now that could access this or that could at one point, only 7,000 of the 70 have been utilizing it, but that's still 7,000 people, and all I've heard was, as Representative Meek said, one complaint. Why are we eliminating that as an option to them? And the follow-on to that, if there's a complaint, why is that not going to the Attorney General's office like all other consumer complaints, and why is it directed through the Medical Board, if you could explain, please?
▶ Play
Representative Hammer, I have no way to explain why a complaint doesn't go to the Attorney General, but as to your, you know, that's not something I would have knowledge of. But as to your other question on consumer choice, there are lots of things consumers would like. They would like to be able to just call up a doctor and get a prescription for Xanax without ever having seen the doctor, for instance. But several years ago, we passed a statute, and you all agreed that that was not appropriate medicine. You agreed with the medical board that you could not get a prescription without a prior in-person examination. So this is not, like I said, free market, consumer choice, all those are great, but the first and foremost principal consideration is patient safety. All right. We're going to move on. We've heard from
▶ Play
Chair Unverified 2:26:59
both people speaking for this, I guess. We're going to skip down to Mr. Scott Ferguson to speak against this. former representative ferguson i should say yeah
▶ Play
i spoke against it so he was in against
▶ Play
Chair Unverified 2:27:19
oh yeah and you're in against but both of our people that are for it were at the end of the table to
▶ Play
Speaker 287 2:27:26
begin with so i'm not calling them okay i'm i'm dr scott ferguson i'm a radiologist in west memphis arkansas i am a delegate to the american medical association i'm on the council of Legislation for the American Medical Association, I was one of four physicians on the subcommittee which dealt with telemedicine and some of the things you hear referenced to. I'm not speaking for the AMA. I'm speaking for me. What's wrong with this bill is the items that have been brought out, the initial patient-physician relationship should be established in person with a health care provider. Doing it by telephone is not good medicine. It's not safe medicine. Several of the questions have been, where can I access this from? Can I call up my physician? You can call up your physician today. You can call up your nurse practitioner today. The example of, I had two kids with the flu and I got a third one. they can call today and say no don't bring him in here's the tamiflu here's what you need that happens today doesn't cost you a penny what they're wanting to do is bill you for it and i guarantee you if you if you called your doctor and said look my first two kids had flu and now my third kid's got the flu can you give me the tamiflu and he said yes and called it in and then sent you a bill you'd be aggravated about it you wouldn't like it uh it's not safe medicine to start the patient-physician relationship without ever having seen the patient. That's the bottom line. It's not safe. It doesn't have to be, once you see the patient, they can call you, they can do telemedicine, they can do all these things you want them to be able to do and we want them to be able to do, but we want them first to have an established relationship. It goes along with the patient-centered medical home, It goes along with everything we're wanting to do preventive medicine-wise. It's the right thing and the safe thing to do. Telemedicine is, it's not a new field, but it is blossoming, as everybody had said. It's coming. We want to embrace telemedicine. We want to do it in a safe way. Somebody else said, we don't want to get out there and reach too far because you can't bring it back in. that's a true statement once it's out there it's out there we want to be safe we want to make sure the patients of this state are protected and a telephone call is not telemedicine it's not good medicine it's not telemedicine we do phone calls every day today that's not prohibited you can still do that you can still call your doctor and have a telephone call and say my kid's sick Can you prescribe me something? They have a relationship with you, and they know you're a kid. They know it weighs this much. They know the allergies it has. They know everything about them. They can take care of it today. So I would beg you to not embrace this bill. The main problems, as outlined, are the in-person. You need to have an established relationship before you can go, and then you go anywhere with this. you don't need to be on a a phone call laying in your bed uh calling somebody on the phone for the first time they've never seen you and say look i'm a diabetic i think i'm in a coma uh can you prescribe me something you don't need that to happen we want to be safe we want to Protect the patients of this state, and I beg you to not endorse this bill. Let's go slowly. Let's do it safely. Let's do it in a manner that protects the people of this state. Representative
▶ Play
Hammer, do you have a question? One. Thank you. Yes, sir. In comparison to the other bill, if I understood the other bill right, it required the initial visit to be face-to-face, and then after that you could go for an extended period of time. So if Teladoc was to amend this bill, that they had a requirement to see a physician first that would be willing to work with Teladoc from that point on, that would resolve the issue, one of the main issues. Is that correct or incorrect? That's correct, and that's one
▶ Play
Speaker 287 2:31:55
of the things we tried to work with J.B. Hunt on was they have a physician, a company doctor. We said, look, you can take that company doctor, do their initial DOT exam, do a history and a physical, and then you can delegate telemedicine services to someone else. So, yes. I'd like to hear the other side respond to that at an appropriate time,
▶ Play
please. Representative McGee, you're recognized for a question. Thank you, Mr. Chair.
▶ Play
Speaker 291 2:32:23
Dr. Ferguson, let me ask you this. We've had a lot of testimony about this company, and they're wanting to bring their services here, and they have testified that their physicians don't prescribe Schedule II medications in the bill. If we pass this bill and allow them in the state, what's to keep other companies that have a similar business model from prescribing those medications? I mean, they may have from their own standpoint, they don't want to do that. And I think they sound, from what they presented, they sound like a very reputable company. But what's to keep another company from having a different set of standards that could be
▶ Play
Speaker 287 2:33:11
hazardous and not beneficial for the Patriots of Arkansas? I guess that's why you need statute or legislation to prohibit, you know, Schedule 2s, where you can't prohibit it. Maybe their company policy does that. Maybe we have a statute that prohibits that.
▶ Play
Speaker 291 2:33:25
But there wouldn't be anything that would keep another company from having a different standard. No, and I guess it wouldn't be anything
▶ Play
Speaker 287 2:33:32
to get this company to maybe change their policy. You know, if it's not one
▶ Play
Speaker 291 2:33:40
follow-up. Yes, sir, one follow-up. Well, could you comment on this? They've also testified that many of the things that they treat are what I would consider as a physician fairly minor medical issues. What's to keep another company from not having those standards? where they could treat potentially over the phone. I'm a physician. I've never believed that the telephone was a
▶ Play
Speaker 287 2:34:05
way to establish a patient relationship. That's my main hang-up is the telephone thing. The follow-up, you know, I think they're going to have reputable doctors. I don't have hang-ups with their doctor panels. and I guess there's nothing to ensure that every company would have that same rigorous adherence to physician panels that Teladoc may have. I guess that's something when you don't know what's going to happen with a particular piece of legislation because it's open. Thank you, Mr. Chair. Yes, Representative
▶ Play
Love, you're recognized. Thank you, Mr. Chair. Dr. Ferguson, make me, I want to go back to something you said. Now, I want you to make me feel comfortable about what we're doing today. You said it was not good or safe medicine to actually do things over the telephone. The initial business. The initial, yes. Now, something that Representative Sullivan mentioned kind of concerned me just in this whole debate. He stated that there was, that we prescribed medicine, psychotherapy medicine or something like that, over the phone initially. I heard
▶ Play
Speaker 287 2:35:25
that. And my response, I think I'm anticipating, if I cut you off, I'm sorry. But that psychiatric patient who needs a psychotropic drug, they've seen a physician. They've seen an emergency room, and then they are referred there. and that's legal under this. Okay, so that's not really their initial business.
▶ Play
We're not cutting that off. Okay. All right, thank
▶ Play
Chair Unverified 2:35:51
you. All right, Mr. Bill Phillips, you're signed up to speak for this. And thank you, Mr. Ferguson. Thank you. Representative Ferguson. Thank you. Dr. Ferguson. I don't know how many titles you have. Former Commissioner. There you go. Former Representative Dr. Ferguson. Dr.
▶ Play
Mr. Representative Ferguson, thank you. Bill Phillips, again, speaking for Teladoc. Let me make sure everyone understands. those of you that were here last week and heard Dr. DePhillips, we didn't go over again today because we went over last week. It is not a telephone call. It's not simply a telephone call. It is at the least a store and forward program where we've had medical records on the individual. It has gone through a vetting process with an individual that goes through your four pages if you ever had heart problems, do you have kidney disease, are you diabetic? I mean, it's the same thing as if a primary care doctor in his office, and you go see him for the first time, you go through the same practice, the same procedures. And to determine whether this guy has got a sinus infection or an ear infection or a sore throat or flu or whatever, you can do it basically over the telephone. But we use interactive video. We have storing forward information. We have a great deal of information on these folks before the doctor ever engages with the patient. It's just a simpler way to get broader medical care in rural areas in Arkansas. Arkansas, I mean, I've heard figures from 39 counties to 73 counties are medically underserved. this is just a way that it's permissive legislation nobody's mandating anybody to buy anything it's safe and it's secure if you want to go into a scare tactic the typical way that you deliver medicine in Arkansas in September I had a growth on my neck and so I went to my doctor and said well let's have an ENT looked at it, and he gave me some antibiotics, and so finally, about the middle of December, I had a growth cut off my neck. It was melanoma, and I went to MD Anderson, and it was stage 4 cancer. If I'd have called a teledoc, and he had that image, and that picture, and those results, and my history, which was, if I had two melanomas removed from my back, he would have referred me to an oncologist immediately. He knew it wasn't a sinus infection. He knew it wasn't just a minor problem. So I would have gotten faster results. So don't let them put horns on this dragon. It's not scary. It's something 12 million folks in America are loving and enjoying. No medical problems. No medical complaints. We are operating in 48 states. We just passed a law in Idaho which will make us eligible to practice medicine telemedicine beginning in July. Those states that I forget what David Ivers said but like a hunch that they will turn red. No. All the states are turning to wear telemedicine. They're embracing telemedicine. Virginia just passed a law. Idaho just passed a law. Many states are passing laws that make it legal. It's just a way that we can get the medical board to allow us to operate in Arkansas and serve these business groups. Mr. Phillips, I'm going to stop you for a
▶ Play
Chair Unverified 2:39:35
second because I can tell everybody's looking at their maps right now and thinking the same thing I am. Are you operating legally in 48 states? Because we've got a major dispute on whether that's right or this is right. I mean, this is direct contrast of testimony, and I'm really curious of which is right.
▶ Play
I appreciate that. I'm going to turn that question over to our Vice President of Teladoc. Thank you. That's a great
▶ Play
Speaker 273 2:40:00
question. I've been sitting in my seat here just squirming because I want to talk about that. I haven't seen that map, so I don't know where it came from. Have you got a copy now? I do not. Thank you, sir. It still doesn't say where they got this information from, so I don't know any more now than I did before. I have no idea where this information came from. But regardless, you've talked to a physician, you've talked to an attorney, I'm a policy person. And so what I do for Teladoc is I go anywhere a state wants me to come and either proactively help them craft legislation or regulation or speak to them when they've got any questions. And so that's what I do. And so I can tell you that, yes, Teladoc is operational in 48 states, soon to be 49 because Idaho passed their legislation two nights ago. We will go back in business there July 1st. Hang on
▶ Play
Chair Unverified 2:40:58
just a second. I think on this other piece of paper it says the American Telemedicine Association's 2014 gaps analysis and I think that is what is referring to this map. Representative Henderson or something somebody and I don't know that this is a sticking point of whether we pass this or not but I can tell by everybody's looks, this is really, I mean, I don't know if I've ever seen testimony that contrasts each other as much as this. So I want to see
▶ Play
Speaker 273 2:41:25
if we can hear this. And again, I don't know where this came from. I can give you one that we've got. But we're operational in 48 states. A lot of states are either silent on the issue and as I said before in my testimony last week, here's rules and regulations and here is technology. And so what the states are doing right now is they're trying to synchronize and they're trying to keep up with where technology is, which is why in 2015 you've seen so much legislation introduced nationwide. But I can tell you that we've got about 133 bills that I'm watching now. 33 of them are priority bills. But in 2015 there were telemedicine proposals. There were nine. And there hasn't been one yet in 2015 that has tried to do what Arkansas is contemplating. All of them, to a state, are trying to increase access and reduce costs. And so having said that, I had a lot of companies here in Arkansas that said, how can my voice get heard? We use this benefit. It's important to us. And by those companies, I mean Cargill's, Golden Living, Car Mart, Halliburton, New Benefits, Centerpoint Energy, Home Depot, Rent-A-Center, Tyson's. how can I get my voice heard? Because with this legislation that's being proposed, you're going to reach into their pocket and you're going to take a benefit away. And I know at the last meeting last week we talked a lot about free market. I'm a free market person. I believe in competition. This isn't a Teladoc bill. This is an access to health care bill in Arkansas. That's what this is about. Competitors want to come in here and do the same thing. I welcome them because I believe in our model. What is trying to happen at the Board of Medicine, quite frankly, is they want to stifle innovation. They want to stifle the free market. They want to stifle competition. But I really, really personally wanted to say that I took offense at someone that would say that a company that these companies that I just mentioned would use a business that is not legal. I find that quite offensive.
▶ Play
All right. And the other thing, Mr. Chairman, is that we never said that there were not regulations in other states that mirror the same regulation in Arkansas, that you have to have the face-to-face. What we said is we are operational in all those states, which means those medical boards have remained silent. They know that their regulation is behind the curve on technology, and they just have not, like Arkansas
▶ Play
Chair Unverified 2:44:02
done, kicked us out. All right. Representative McGee, you're recognized for a question.
▶ Play
Speaker 291 2:44:10
Thank you, Mr. Chair. So I've heard some testimony about the fact that this also has audiovisual, and it implied that that's what happened all the time. but in Teladoc's own website, they say that Teladoc phone consultations are available, 24 hours. And it says that they do, while some videos are available, seven to nine, seven days a week. So I get the impression, or I don't get the impression that it's all audio-visual. I mean, some of this, what happens to the patient, it's a telephone call, and during the day it could still just be a telephone call and not have the video part. I mean, to me this is all about patient care and what's safe for patients and whether or not our medical board has the ability to protect the public. That's their charge is to protect the public. And maybe they've drug their feet on some regulation that needed to be passed, But at the same time, they felt at the time they were protecting the patients. And maybe they'll get the message now that there are a number of individuals that want or need this service. But I have a real problem circumventing the very board that's established for the patient's safety. I'm not discounting that Telagox is not a good company, safe company. I just have concerns. We open this door, and, you know, even in the states, many of the states that have statutes about this define it as telemedicine does not include provision of health care service through audio-only telephone. How do you respond to that? How do you do that in those states? And we support
▶ Play
Speaker 273 2:46:10
that, that we don't do audio-only, so we support what you're saying. Yeah, and
▶ Play
we're not getting around that at all. If we have the medical history downloaded, stored, and forward, we have the forms fill out. I mean, it's just like whenever a new patient comes into your office, they have to fill out the four or five or ten pages of history. I mean, we have that on file before the doctor ever talks to that patient. And the reason is that we're here with this bill is not circumventing the medical board. But they told us if you want to fix your problem, you go to the legislature, and that's why we're
▶ Play
Speaker 311 2:46:50
here. I don't know. That might be a
▶ Play
matter of interpretation. Thank you. Let me respond just real quickly. We just heard the doctors and the witnesses brag about how much they do telephone services, and this is no different. We just rehearsed that, and I might submit that maybe it's not their feet
▶ Play
Chair Unverified 2:47:09
that are dragging on this. It's time to move forward. All right. So Representative Sullivan, you're recognized, closed for your bill. Thank you, Mr. Speaker, and I appreciate the
▶ Play
indulgence of everybody and the time, and I'll do it quickly. Let me speak to the point of establishing that initial relationship. If you'll remember, I asked the question during the other time that it would be possible for a patient to see a doctor and go 1, 2, 10, 20 years before ever seeing that doctor again, and they would still qualify under that other legislation. It's beyond me how one cannot see a patient for 20 years and then say there's value in seeing that initial patient. That means a child, you could see them at 1 and do their initial sight, and they could be 20 years old and still be making a phone call asking for those drugs, asking for that same prescription. There's no value in that. There's not as much value in that initial visit as this bill places on it. You know, folks, this has turned into a much more controversial issue than I thought it would be, and I'm really disappointed to hear some of the claims made against opportunities for Arkansans. Some of the things that, examples that were described just before Mr. Phillips got up here were said four or five or six times that is not what goes on. There are folks that are trying to portray the fear factor here and trying to scare this committee into voting down or not supporting opportunities for choice for Arkansans and I would hope and ask you to give us an opportunity with this bill to move forward with the next step to allow further conversations to go and most of all to allow the citizens of Arkansas an opportunity to make their own choice thank you and I appreciate a good good vote and I would also make
▶ Play
Chair Unverified 2:49:07
a a motion do pass. All right, members, we have a motion do pass. You would like to speak to the motion, Representative Hamm, are you recognized? Thank you,
▶ Play
Mr. Chair. I believe that maybe there has been a little bit of, in my opinion, that there's been a little bit of a cloud of confusion that these two bills that we've been discussing today compete with each other. In my opinion, I think they're two separate issues even though there's some similarities between the two. And if we pass this bill just as much as we pass the other bill, then we at least have a two-year window to allow an opportunity instead of having to wait on one bill another two years for an opportunity to be determined. So with that, I'd vote. I would encourage a good vote on this to pass it so we can give equal opportunity.
▶ Play
Chair Unverified 2:49:56
Members, any other discussion? Seeing none, all in favor say aye. Aye. All opposed? No. Chair rules. Ayes have it. Roll call. I see two hands. Roll call it, Mr. Price.
▶ Play
Speaker 315 2:50:15
If you would, yes, sir. Okay. Representative Sullivan. Yes. Representative Henderson. No. Representative Boyd. Yes. Yes. Representative Bentley. Yes. Representative Lundstrom, Representative Payton, Representative Fite, Representative Bragg, Representative Womack, Representative Miller, Representative Miller, Representative McGee? No. Representative Ritchie? No. Representative Overby? No. Representative Meeks? Yes. Representative Branscombe? No. Representative Hammer? Yes. Representative Wardlaw? No.
▶ Play
Speaker 230 2:51:33
Representative Love? Yes. Vice Chair Ferguson? No. I won't vote. You're not voting? Okay. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11.
▶ Play
Chair Unverified 2:52:03
All right, with 11 yays, 7 nays, and 2 not voting, your bill has passed. Congratulations. Thank you, Mr. Chair. Thank you, committee. Representative Gray, you're recognized for the next special order of business. By the way, members, we're all working through noon. We have five special orders of business, and that means we will get through them. I think you have a Senate bill. It's 688. Is that right? I think that's the right number.
▶ Play
Yes, that's correct. Thank you, Mr. Chair. With your permission, I would like to have Mark Riley with the Pharmacists Association with me to help present. Absolutely, and
▶ Play
Chair Unverified 2:52:44
I think Mr. Riley's been around long enough to know that he can introduce himself for the record, and y'all are
▶ Play
recognized. Thank you, Mr. Chairman, members of the committee. I'm Mark Riley with the
▶ Play
Arkansas Pharmacists Association. all right members this bill senate bill 688 senator collins is the lead sponsor and he will be here after he is through with his committee this bill does two major things there's been a lot of talk and a lot of speculation and i encourage you all to please ask questions as you see fit so that everyone understands what this bill does the two major things that this bill does well let me start with definition so everyone understands what this bill deals with is what they call PBMs or pharmacy benefits managers pharmacy benefits managers are essentially the middleman say we've got an employer we're going to call the employer and I'm going to use Tyson my brother-in-law works for Tyson I'll use Tyson Tyson's the employer Then you have a PBM, the benefits manager, and then you have the patient. So that PBM essentially processes all of the prescription claims that come through from the pharmacies on behalf of the employer. So what the current issues that we're having right now are PBMs are reimbursing pharmacies pharmacies below their acquisition costs on a substantial amount of medication. That's one of the issues in this bill we try to address that to some degree. We have an appeal system set up already in place and we're just adding a little bit to that appeal system. Right now when a pharmacy appeals, and this number comes straight from Express Scripts, the appeals that are actually approved are only 18 percent of what is sent in and most pharmacists send their invoices their entire cost in with them when they appeal so we're trying to put a little bit more teeth in that one of the other things that we're having issues with is we've got in this bill that a pharmacy benefits manager shall not reimburse a pharmacy or pharmacist in the state an amount less than the pharmacy benefits manager reimburses an affiliate for providing the same service. What we're running into with pharmacists is the pharmacy may fill a prescription let's say they get reimbursed $40 for a script of 30, 10 milligrams. That same prescription could be sent in to an affiliate pharmacy so one of the PBMs, they have their own pharmacies and their own mail-in pharmacies, that same prescription is getting filled at a reimbursement cost to that pharmacy of $245. Same medication, but different reimbursement rates. And so this bill tries to address that, and it says that these PBMs cannot pay their own pharmacies or their affiliate pharmacies a price that's different than what they pay the rest of the state and the independent pharmacies. Now, they could adjust the price up or they could adjust the price down. We're not price fixing in any way. We're just saying that the independent pharmacies deserve, the rural pharmacies in my area, the ones who don't have a huge voice, someone to stand up for them, they just want the opportunity to be able to sell their products at the same price, to get reimbursed at the same price that the people who are controlling the price get to do it. the third thing that this does and I think there's a lot of heartburn with the PBMs on this one particular issue right now if a pharmacy has a prescription let's say that the cost to the pharmacy is $40 the PBM is only going to reimburse $10 to the pharmacy so the pharmacy is going to lose $30 right now the pharmacy is required by their contracts with the PBMs to fill that medication at a loss If they refuse to fill that medication, their contracts can be canceled. And so all we're saying in here is that the pharmacists have the right not to fill the prescription just so they don't have to take a loss without fear of their contracts being canceled. Right now, there are three major PBMs, and they control about 70% of the market share. So people say, well, just let them cancel their contracts. We can't because if a pharmacist loses one of those three major contracts, they are out of business. It's done. They cannot lose one of those three major contracts. So I don't want to say it's a monopoly, but it's almost to where they've gotten so big they control the pharmacist. The pharmacists don't get to set their price on the medications. You may go to the pharmacy and think, you know, why does this cost so much? That's the PBM. That's the middleman sending back. This is what you're going to charge. The pharmacist has absolutely zero say-so in that. So those are the major things that we're trying to do with this bill.
▶ Play
Mark, do you have any additional comments? Just a couple of things. I know the committee's been here a long time. Prescriptions were traditionally, for most of our lives, those of us that are older, were the cost of the drug, which a manufacturer, whoever makes it, determines what the drug costs and what the pharmacies paid, whatever they made on it. Well, we've moved in the last 25, 30 years through a progressive situation where there's three factors in this now. There's what the drug costs, there's what the pharmacy makes, and there's what the person makes in the middle. There's a lot of money flowing in the middle, and you can go look at Wall Street numbers, and I didn't bring those, but there's a lot of money being made being a middleman in this business. A couple of things I'd like to mention. There's questions that I've probably been asked more than anything else. Well, is this bill going to raise costs? Is it going to raise costs? The way I'd like to address that is if you tell me I'm getting paid, if the drug cost literally costs me $40 and I get paid $20 and then the PBM is required to cover my $40 cost on the cost side of the equation, that's the way it's set up, cost plus a fee, then I guess you could say it would raise costs. But I didn't raise the cost, the drug company did. And then pharmacists are being asked to fill it below that cost. My question in reverse is are we in a position where cost-saving strategies for the PBMs and or the employers is that pharmacists are going to be paid under cost. They're going to put it, you know, we don't want our cost raised, so we're going to keep paying you less. That's a train wreck because it may be 10% of them now. Is it going to be 20% next year, 30%? Because drugs are going to keep going up. They never have stopped going up. But I look at it this way. This is a visual, a simple visual. The PBM charges the employer a number in generic drugs. This is nearly how all of them are charged out. They charge the employer a number. They pay a pharmacist a number below that. There's a spread, you've all heard about that, that goes on. The PBMs do not generally pay the pharmacist what they charge the employer. They make money in that spread. What we're seeing in the last two or three years is that then we're seeing price compression on the pharmacy. So if the employer's being charged $40, the pharmacist is being paid $30. And let's say that $30 is cost, that it's somewhere around fair. But then the pharmacist gets dropped because the PBM does it when they want to. It's their total choice. So they drop the pharmacist to $25. What happened? They just made $5 more. So what if they drop it to $20? They make $5 more. So when you say it automatically causes increases, it could cost an increase if the employer was paying that. But many times it's just a matter of this. Employer's cost didn't necessarily change at all in the spread game. We don't know that. We don't know, but we know that we get charged, We get driven way through the floor on the cost, and we know the employer is paying a completely different cost. And so there's an incentive for the PBM in the equation to always push the pharmacy down because the wider that spread gets, the more money they get to keep in the middle, and it may have nothing to do with what the employer's cost. So that's a factor I think we need to look at. And that's pretty much it. I mean, I think our pharmacists, I would just say this, and as I close my part, that the PBMs affect us every day. They change prices every day. They send out addendums to us. The pharmacists really have no power in the equation. As she said earlier, it's an oligopoly is what we call that, where there's two or three companies that control the market. We get one chance every two years to come down here, and I know it's a bloodbath, and I know y'all don't enjoy it. And we don't do it because we enjoy it. but we have 750 pharmacies in Arkansas, and it's not just independents. We've got Walgreens here today. We've got Fred's here today that have significant numbers of stores in our state, and they're all under the same pressure, and we get one chance every two years for our folks to come down and say this is unfair. We're in a situation where we have no control, and we can't even say no. We don't set the prices. We don't determine what we get paid on any of the prescriptions, and it's total in control of the PBM who is just a classic middleman who is making money on every time we get cut, and that's wrong. And we appreciate your help.
▶ Play
Chair Unverified 3:02:21
All right, I'll be open to
▶ Play
questions. Representative Payton, you're recognized. Thank you, Mr. Chair. I get the equation you presented there, and I understand there's a real problem. And we've definitely allowed a free market system to get convoluted until the middleman has a lot of power and a lot of price-fixing ability. But on the other side of the pharmacist is another middleman called the drug wholesaler between the manufacturer and the pharmacist. And from what I've studied in your bill, we are now going to guarantee the pharmacist that they would not be reimbursed below what they pay that wholesaler. And I have grave concerns that we're going to turn another middleman loose to charge whatever he wants to charge to the pharmacist because the pharmacist is going to be made whole by the fact that this law guarantees them reimbursement will not be below what they pay that wholesaler. So I hate to have a problem with one middleman and try to fix it and create a problem with the
▶ Play
other middleman. May I address that? This bill doesn't change the incentives in place for the pharmacist to buy the best they can for this reason. Let's take three scenarios. We're paid at cost, we're paid $10 above cost, we're paid $10 below cost. I think that would take all three possibilities. Let's just use that. In all of those cases, I'm incentivized as a pharmacist to buy the best I can because in all three of those cases, if I can buy that product a quarter cheaper, I'm still better off. If I made 10, now I made 10 and a quarter. If it was at cost, I made a quarter. If it was below cost, I lost 25 cents less. So the incentive for the pharmacist to buy as low as they can will never change, and because of that, the wholesaler will always have to be beholden to keep their prices competitive because if they don't, we'll change wholesalers. So I don't think we're changing our incentives at all. Okay, if I could follow up, Mr. Chair.
▶ Play
Yes, sir. And I see what you're saying. The way the problem got created on the side you're trying to address is almost a monopoly. How many wholesalers and what competition is there on that side of the equation for the pharmacist to shop around for that best
▶ Play
price? There are five full-line wholesalers doing business in Arkansas. Full-line meaning every one? Full-line meaning major wholesalers. Then there's other companies that sell smaller amounts of drugs. They're what we call secondary wholesalers in the marketplace. But there's five that choose from in Arkansas that are doing significant business in Arkansas. Thank you,
▶ Play
Chair Unverified 3:05:14
Mr. Chair. Representative Meeks, you're recognized. Thank you, Mr. Chair. And I'm referring to page 4, line 27 and line 28. and I'm sure that there's a valid reason as to why we're excluding the employee benefits divisions of the Department of Finance and Administration from doing this. But on the appearance sake, we're again showing our constituents and the voters of Arkansas that it's good for everybody else, but apparently it is not good for state government and we're excluding ourselves. So if you could talk about those
▶ Play
concerns. Well, the reason it's in there, typically, we've been asked to do that. We've been asked to exempt Medicaid and those kind of programs. But if you look right under it, it says when either one of those programs use an outside PBM to handle their MAC list or their pricing list, then they are under the bill. It's simply when they do it all in-house. And here's the reason that we don't have a lot of heartburn about that, because if it's Medicaid or state employees, we have an avenue to come to y'all if it becomes totally unfair. We have an avenue to talk to committees and to talk to folks in the legislature that can address that quickly. And there can be a discussion, there can be hearings, there can be all kinds of things if those programs get completely out of hand. And so that's the reason that we separate them out. And, again, if they do use a PBM controlling their pricing and their MAC list, then they are under the bill.
▶ Play
Chair Unverified 3:06:42
That's what the next one says. Yes, sir. So just to help me in my knowledge or whatever, since we're not using a pharmacy benefit
▶ Play
manager, what are we using now? Well, for the Medicaid program, they're using what we call a fiscal intermediary. They don't make any decisions about the prices. They just process the claims, which is what the PBMs originally did. you know but but but it's morphed the state employees actually does use pbm right now and they're looking at changing that possibly in the future because they're not happy with what's happening uh within the pbm problem and you know senator hindron has led the task force to deal with that and and we've we've helped address that and so so right now the state employees would actually be under this is if they continue to use the pbm medicaid would not because they simply use a processor.
▶ Play
Rep. Smith-Hammer, you're recognized. What I need a clear distinction on is the larger chains, it would seem that the larger chains would have the ability to absorb this in the event that this bill does not go through. What I'm trying to understand is what's the impact on the mom and pop, the individually owned pharmacists, if this bill does not go through, and can you draw a comparison line, please?
▶ Play
well first of all there probably is some more leverage when you're getting to be really large except i would remind folks that about two or two years ago a little more that there was a battle between walgreens and express grips and walgreens folded their cards because they could not do without that business uh it was just too large a part of their business but back to your point about the smaller pharmacies they literally have no leverage at all and and you know as being the director of the pharmacy association i monitor the problem based on how many calls i get and this is daily i mean i have stacks this high on my of just underpaid prescriptions on my they're sending them to me constantly i can't keep doing this uh you know i don't want to get it i know this is anecdotal but i think your question would relate to that you know i've had pharmacies call me in tears i can't pay my bills i'm laying off people i'm gonna have to shut down because too many of my prescriptions are being paid under cost and so I just talked to Billy Newton outside where he once had a prescription he lost $200 on he told the person that he said I just can't fill this prescription all these $200 the person went and called their PBM they called him back and said you feel it or we're kicking you out of the network I see no further questions I've
▶ Play
Chair Unverified 3:09:17
folks signed up to speak for and against we'll start with against Alan Horn. If you would, introduce yourself for the record and you're recognized to give testimony. Thank you, Mark.
▶ Play
Speaker 345 3:09:43
Thank you, Mr. Chairman. My name is Alan Horn. I'm Vice President of Government Affairs for CVS Health. CVS Health is the parent company of Caremark, of CVS Pharmacy and of MinuteClinic. I first wanted just to refute some of the claims that have been made earlier and then I'd be happy to walk through the bill and the problems that we have with the bill. I have a lot of respect for Mr. Riley. He and I have known each other for a long time. He has my cell phone and he doesn't hesitate to call me. We've been friends long enough that I didn't have to wear these glasses, but I do now. A couple of the comments that were made regarding a pharmacy would be out of business if they did not contract with one of the top three PBMs. It's absolutely incorrect because we don't contract with every pharmacy in the United States. We are one of the largest PBMs. We contract in our national network around 96 percent of all pharmacies in the United States. But that still probably leaves six, seven thousand pharmacies that are operating in the country that do not have a contract with Caremark. So just wanted to clarify that you can exist without having a contract with one of the top threes. Mr. Riley referred to spread. We get a payment from the plan, we reduce that, and then pay the pharmacy. I don't think he intended to represent that that's every way in which we contract, because it is absolutely not. We have 2,000 contracts with Caremark, so we have 2,000 different payers or clients, whether that's an insurance company, a health plan, whether that's a union, the state or federal government, or our commercial clients. Many of them have in place a requirement, which we call in the industry, pass-through pricing. Whatever they pay us, we pay the pharmacy. But that control resides with the plan, the payer. It is not the PBM's money. Technically, when you look at that arrangement, we are contracting with the entity, with the payer, to implement their prescription drug program. So they can choose to have a pass-through pricing. We have that with many of our clients. Again, what they pay us gets paid to the pharmacy. Talked about updating of, and Mr. Riley referred to the changing of drug prices, and absolutely, I agree with him that generic drug prices are changing constantly. We update our pricing very frequently. In fact, in this state, there's already a requirement that we worked on years ago that we update within seven days. We update a whole lot quicker than that, but in this state, seven days. So there is updating of pricing currently happening. To walk just briefly through the bill, we have several problems, but I think I'll just concentrate on a couple. I didn't really understand the math about how this wouldn't cost money in guaranteeing a reimbursement rate and how the incentive would not be there to purchase a product at the lowest cost available, which is what a MAC list is intended to do. We talked about the Medicaid program. They use a MAC list. Forty-six states use a MAC list in their Medicaid program. MAC lists are not just for private clients. They're also in the public domain, whether that's the federal government or state governments. But this bill does say we must reimburse, and again, we, the PBM, because we're handling between the plan and the pharmacy, we must reimburse at a rate equal to or higher than their acquisition costs, no matter where they buy it. Again, we don't have control over where a pharmacy purchases their drugs. Most pharmacies, small pharmacies, are part of PSAOs or buying groups that operate on their behalf. We don't know and are not privy to where they're purchasing the drug. Are they purchasing it at a competitive rate? So therefore, you could, and the question was asked, could you go to the highest cost wholesaler, buy the drug? Absolutely, because you know you're going to get reimbursed. So I fail to see how this brings drug costs down. We talked about, there was talk about a provision in here about refusing to fill a script. And I'm not going to sit here and tell you that pharmacies make money on every single prescription. prescription. There are many, many prescriptions where pharmacies make more money than what they're reimbursed and especially, as Mr. Riley said, if they're a good purchaser of that drug. They're going to make more money. Overall, in a market basket, you're making money on your entire book of business. Are there those cases where a drug comes up and the reimbursement is significantly lower? Yes. We have an appeals process internally. We are, if we'd had an opportunity to sit down and talk about this bill, we probably could have put some more teeth in and talk about appeals process and a more robust appeals than what's in statute. The provision that would allow a pharmacist to not fill a script, So here's the scenario that happens. A person has three scripts, and they go to pharmacy A. Pharmacy A says, well, I'll fill two of them, but I'm not going to fill your other two, so you're going to have to go somewhere else. So now you've got an enrollee going to another pharmacy. They get to the other pharmacy, and the pharmacist says, well, I'll fill one of them, but I'm not going to fill the other one. So now they've got to go to the third pharmacy. And I don't know how you find out in this scenario what pharmacy you can get your script filled at. that's only going to lead to a lot of confusion with the enrollees and your constituents not knowing where they can get their drugs filled at the end of the day. I know you've heard a lot from both sides. I just briefly ran over some of the problems. There are other issues in the bill, but I think those are some of the key points and would be happy to answer any questions that you may have.
▶ Play
Representative Payton, you're recognized. In your pricing model, now you're the middleman we were talking
▶ Play
Speaker 345 3:16:33
about earlier, right, one of them? I represent CVS
▶ Play
Health, and we own Caremark, yes, sir. Okay, in your pricing model as the PBM, not as the pharmacist, do you lose any money on any of the
▶ Play
Speaker 345 3:16:48
prescriptions? Does Caremark lose money on a prescription?
▶ Play
Okay, we have the employer, we have the PBM, we have the pharmacist. That's correct. Are you the PBM? Yes, sir. In that pricing model, do you lose money, or what percentage of your products have you priced below your cost? We don't purchase
▶ Play
Speaker 345 3:17:04
any drugs, so in that scenario. You have an established amount that you charge the employer, right? It depends on the way the contract
▶ Play
is structured. Okay. In those contracts that are structured, where you have an established price to your customer, is there ever a case where that price is below your established price with the
▶ Play
Speaker 352 3:17:34
pharmacist? Okay, you're asking the pharmacist to lose money
▶ Play
from where they purchase the prescription to where they sell it to you. Okay, is there ever a case where you choose to lose money because the overall book of business is profitable? Is there ever a case on a certain drug where you choose to lose money in order to facilitate the entire
▶ Play
Speaker 345 3:17:58
book of business to your customer? Well, I think part of it, it's not our money. It's not the PBM's money. It's the client's money. So let's, first of all, it's the client's money. You operate on zero margin? It's not the, I'm sorry? You operate on zero margin? No. I mean, well, I will tell you, we have many contracts. Some of them say, we'll just pay you an administrative fee, and that's all we want you to do. Some say we'll pay you a percentage. Some have a transparent. There are very different ways in which a payor can structure that contract. So do you know the answer to my question? Your question
▶ Play
is we get paid $5, right? Yeah, do you ever lose money? Do you ever lose money
▶ Play
Speaker 345 3:18:46
on a particular prescription? But we're not purchasing the drug is what I'm trying to explain. I mean, we're not the purchaser of the drug, so we're not purchasing a product, so we're not losing money on a product. We don't have that product.
▶ Play
Have you ever lost money on the overall
▶ Play
contract? I don't know the answer to that question. Okay. Thank you, Mr. Chair. Yes, sir. Representative Hammer, you're recognized. Let me take a pickup run on what Representative Payton was asking. As a PBM, are you ever in a position that because of somebody else's decision,
▶ Play
Speaker 345 3:19:30
you would lose money? If a contract is structured in a way that we may want the contract, but we're willing to take a haircut, potentially yes. How many contracts do you have now that you get a haircut on? I can't. We have 2,000 clients. I don't know the
▶ Play
answer to that. And regarding a comment that was made a while ago at the end of the table by somebody else about the pharmacist who couldn't fill a particular prescription because they were going to take a $200 loss and received a call by a PBM saying, fill it or you'll lose your contract, I'd like to hear you elaborate on that. i don't know if
▶ Play
Speaker 345 3:20:12
he was directly was that care mark i mean well would care has care mark ever
▶ Play
done that or would care mark ever do that under the terms of the contract you have
▶ Play
Speaker 345 3:20:24
with your pharmacist that you provide to there are two ways and i alluded to one of them a minute ago if there is a substantial price difference we have an appeals process both in statute and a more robust one contained within our provider agreements with the pharmacist. So there is an avenue to have that discussion. I will tell you that our rate, the rate that was mentioned about express scripts, ours is a little bit higher than that. And is there an instance where we say you need to fill the script because you have a contract in order to keep enrollees access and have access to pharmacies that is the reason that we contract for them to fill all of the scripts so that they're not shoved from one pharmacy to another to a third to a fourth mr chair one last question
▶ Play
if i may sure here's the dilemma i find myself in i want you i want you to give me your explanation and then when the other side comes back table i'd like to hear their explanation in my opinion we're kind of in a in a rock and a hard spot you've got independent pharmacists as far as i know anybody that contracts with the pbms are in the same position whether they're a chain pharmacy or independent pharmacy that are kind of at y'all's mercy that if they don't go along then they're out of business or they're continuing to take losses on the other hand i don't really want to be sitting here as a lawmaker getting in y'all's business and mandating that you as a PBM will come to the table and play nice so I'm just wondering based on history why we're even having this discussion in the first place and how it's going to impact you know how it's going to impact both you in the future and the other side on
▶ Play
Speaker 345 3:22:16
the in the future I appreciate the question and I think Mr. Riley and I have long known each other long enough, and he's heard me say this consistently throughout the years, rural, small, independent pharmacies are extremely important to Caremark. I hate that this debate comes down to PBMs versus smaller pharmacies. I'm from Texas. We have a lot of rural areas, as you do here. We have access requirements that are contained within our contracts with the payers that basically say we don't want our employees driving x miles and they'll determine what that is so in that instance we have to have pharmacies out in the middle of nowhere mule shoe texas it's a great place we have department of transportation we have the state contract in texas we have department transportation employees out there we need that pharmacy in the network independent and small rural pharmacies are extremely important uh to care mark indulgence please mr chair
▶ Play
a little more okay I feel hypocritical because we're invoking the rural aspect of this discussion but I've got a pharmacist standing against the back wall that's feeling the pain of this that is not in rural he is in a very one of the most heavily populated counties in the state and I'm wondering under the contractual terms is there any consideration if you're going to invoke that argument that you would be able to treat the rural pharmacists that you have cited as the example for why you're doing this against the other ones or what's problematic about that as far as contractual specialization to the need so as not to spread the cost out among everybody if we've got one particular problematic area? I think if you have
▶ Play
Speaker 345 3:24:01
a pharmacy that is in a very rural area, it more than likely is reimbursed at a higher rate than if you have an independent in downtown Little Rock or downtown major city, simply because there's a need to have that pharmacy in the network. I hope that answers your question. If not, I'd be happy to try and – there is a need. I mean, there is absolutely a need for those rural pharmacies, And we have contracts with almost 100% of the pharmacies in this state. That's all the questions I see, so we're going to bring
▶ Play
Chair Unverified 3:24:41
up Ms. Polly Martin to speak for this. Thank you, Mr. Chairman and members. Thank you. And Polly, I think you know the routine
▶ Play
well enough, too, don't you? Thank you, Mr. Chairman. My name is Polly Martin. I'm with the Arkansas Grocers and Retail Merchants Association. They're passing out a letter. I emailed it to you, but I wanted you all to see it on our letterhead. Our association represents about 1,000 storefronts. No one in my association is against this bill. I have large pharmacies I have small pharmacies I have a couple of independents even and they for the reasons Dr. Riley has said it's a cost thing to them and other than that I think they've covered Representative Gray and Dr. Riley have covered about everything I had to say so So you all can see the list of people. And one of my small regional chains is very much for this,
▶ Play
Chair Unverified 3:26:04
and he had to leave earlier, so he couldn't talk. Any questions for Ms. Martin? All right. Thank you. Thank you. Speak
▶ Play
Speaker 366 3:26:27
against me, Julie Mullenix. Mr. Chair, members of the committee thank you for allowing me to speak to you today Our firm represents Be sure and introduce yourself I'm Julie Mullinex Our firm represents Express Scripts a company that has contracts with Arkansas employers who negotiate their contracts to provide pharmacy benefits for their employees, your constituents. If you choose to pass this legislation, you will be interrupting contracts that Arkansas employers have negotiated. Employers face increasing regulation and cost and they have negotiated these contracts to allow them to deliver pharmacy benefits for their hardworking employees who are your constituents. If you choose to pass this legislation, you take away the incentive for pharmacies to purchase the lowest cost generic drugs, resulting in increased cost to the employers in your district, and ultimately increased cost for their employees, your constituents. Hometown pharmacists are an important part of rural Arkansas. We all know that. But if this bill is passed, what industry will be next in line to ask state government to get in the middle of private contracts? And is that the right thing to do if those result in increased cost for your constituents? In addition to the cost concerns, we believe there is another unconscionable provision in this legislation that allows pharmacies to decline to fill prescriptions if they're not making a profit on that particular transaction. The establishment of a network of pharmacies is a foundational part of the whole delivery system for PBMs. Your constituents, the employees, know which pharmacies are a part of the network that their employer or the plan offers to them. If those network pharmacies can choose which prescriptions they fill and which ones they do not fill, the whole delivery system is disrupted. Those being turned away will be among those hardworking folks that need this coverage the most. they will not be the ones that can reach into their pocket and afford to pay for those prescriptions out of their own pocket. As I told you a moment ago, our client, Express Scripts, does represent a number of employers across the state. You're being handed a list of employers who pay for these plans who oppose this bill because of increased cost. You're also being provided a letter from Tyson Foods that outlines the reasons they oppose the bill. And I want to draw your attention to, in the Tyson letter, the last sentence in the first paragraph. To avoid a significant increase in cost to our health plan, passage of this bill would require us to consider excluding small pharmacies from our Arkansas network and drive our participants to the larger pharmacies that we contract with directly. Our direct contracts with Walmart, Harps, et cetera, are not based on MAC pricing, and that probably is the reason you heard earlier that Walmart is neutral on this bill because they do have direct contracts. Finally, I also spoke on the phone this morning with the Senior Vice President of Human Resources at J.B. Hunt and he asked me to share a message with you. And I have that written here. We are concerned about Senate Bill 688, the MAC pricing bill being considered by the Arkansas
▶ Play
Speaker 370 3:30:37
General Assembly as we believe it unduly interjects Hang on. I've got a point of order. Rep. Sam
▶ Play
Chair Unverified 3:30:43
Hammer? I'm sorry. I didn't hear that. It may be a point of clarification, but I was under the understanding that we cannot hear have somebody read a letter because they're not here to answer questions, if that's correct. Okay. That is correct. It's a good point of order. Thank you. Thank you. I should have got it in writing. Thanks. And Rep. Sam Hammer, you have a question for her or for me? okay well let's finish your testimony Ms. Mullinex that concludes my testimony Representative Hammer has a question thank you
▶ Play
Ms. Mullinex what I'd like you to speak on or anybody that comes to the end of that table is it seems like I've heard there is an appeal process for the pharmacist when they get in a situation where it involves the scenario of a $200 cost that they're going to have to absorb or they're going to be kicked out of the PBM threatened which I find kind of repulsive but anyway They speak to the appeal process and why there's such a backlog and where the problem is about these pharmacists getting timely response and basically being caught having to hold the bag on the money. Could you speak to that, or if not, whoever else comes in at
▶ Play
Speaker 366 3:32:02
the table, please? Representative Hammer, I do not know the answer to the question about the anecdotal.
▶ Play
Chair Unverified 3:32:09
Because of that question, apparently, Mr. Horne does know the answer. I'll allow you to come to the table and
▶ Play
Speaker 345 3:32:17
answer that. Thank you, Mr. Chairman. One of the things that we have passed in other states and we are quite comfortable with is putting in a timeline by which the PBM shall respond to the pharmacy. many and we've been told that there are and there are a number of PBMs operating out there I don't know how many I'm not even sure Mr. Riley knows but we are committed to responding in a timely fashion to those pharmacies and in other states and I've negotiated probably 15 of these bills we have put in statute that the PBM would respond to the pharmacy typically it's around 15 days we give them 15 days to file an appeal and we have 15 days to respond follow up and you have
▶ Play
follow up yes sir what is the current time in the state of arkansas for pbms
▶ Play
Speaker 345 3:33:16
to respond i don't believe we have one in here when we did this is it seven days more um this was one of the first bills that ever i think may have passed in the country that you and i worked out years and years ago, and I think we've gotten better over the years in putting things into statute on both sides, but we are quite comfortable with having a timeline or time frame to which to respond to the pharmacies. I think that's only appropriate. Okay.
▶ Play
I didn't hear the answer to the question, though. What's the current time restriction in the
▶ Play
Speaker 345 3:33:53
state of Arkansas? I was looking over at Mark, and he tells me it's seven days to respond. I'll go with that. I don't have the current statute in front
▶ Play
Speaker 376 3:34:06
of me. The current bill says seven days. The bill before says seven days? This bill that
▶ Play
Speaker 345 3:34:11
we're amending says seven days. But he was asking about current law, and I don't believe that there is a current
▶ Play
Chair Unverified 3:34:16
timeline. There's nothing in statute, but there may be something in contract.
▶ Play
I don't know. Excuse me. This bill is – we passed this
▶ Play
Chair Unverified 3:34:25
bill two years ago. So the current statute is seven days. Gotcha. Okay, I see. In the content of this bill is existing statute that says seven days. I
▶ Play
think that's what we're saying. Okay, so even with seven-day mandatory response time for the PBM, there's still a problem with the pharmacist either not getting paid or there's still a dispute ongoing. Is that correct?
▶ Play
That is correct. We may get a response. We may not get a response in seven days. And if we get
▶ Play
Chair Unverified 3:35:01
a response, it's been no most of the time. Thank
▶ Play
you. All right. Representative Payton, you recognize. Thank you, Mr. Chair. I've been sitting here mulling over what's been said earlier, and I remembered a point. The PBM also, in many cases, as is your own, owns pharmacies. and it's been said that the reimbursement rate to your own pharmacy is higher than a reimbursement rate to another pharmacy. So there is a provision in this bill that would say that you had to reimburse your pharmacy or change their reimbursement to where that would be level playing field. Would you be opposed to that if that's all the bill did? the
▶ Play
Speaker 345 3:35:50
problem with that is that you have different payers and i again i alluded to one that has that could have a transparent model which we call and that you have to reimburse exactly what the plan pays so there's no right but i'm not talking about that but you can't when you when you start making payments uniform across the board, you get into trouble because you may not want to reimburse the downtown independent as you do in the rural independent. You may want to give that rural independent pharmacy more reimbursement for whatever reason. what we're paying to a care mark pharmacy and it's not really a payment it's what it's being filled as it's just part of the contract that we have with the payer so if
▶ Play
i could follow up yes sir so you would be willing to level the paying field if they were within the same zip code No Okay, thank you Mr. Chair
▶ Play
Chair Unverified 3:37:04
Representative Henderson you're recognized Thank you
▶ Play
Mr. Chair I am glad there's lots of pharmacists here today because I'm starting to get some heartburn and there's some stuff on both sides that that I just really don't like But, and you said, Mr. Horn, you said something a while ago about you, y'all have negotiated some, I guess, some deals between both of you before. Can you see any common ground that y'all have? Looking at the bill at hand, I mean, there's some stuff that's not really just really great in the bill. and looking at your side, there's some stuff that's not really jives really good on your side, too. And either of you can answer. Can you see any kind of common ground? I'll go first. I
▶ Play
Speaker 345 3:38:04
mentioned a minute ago that I've negotiated 10 to 15 of these MAC, maximum allowable cost bills in other states, and we have come to, in every state that I've worked in, with negotiating with the pharmacy association, with the independent pharmacy associations, which I just did in Texas. We'll have a bill this year. We've always been able to come to some agreement. The difference here is that you're guaranteeing a profit in statute, and that is something that has not happened in other states because of the cost increases to the plan sponsor. So, yes, are there some things that we can expand upon and work on in this? Absolutely. I think you could tighten up the appeals. I think you could make it more in line with what the business practices of Express Scripts and Caremark are. Absolutely. Responding. You know, if somebody doesn't respond, the insurance commissioner, in my mind, ought to be able to step in and say you didn't respond, you didn't do what you're supposed to under the law, and then there's a process to fix that. and
▶ Play
Chair Unverified 3:39:16
i think we have i don't know that i really want to start a debate within the table but that's what we have i'm going to recognize miss mullinex for a point then you for a point that i'm going to ask miss gray to close because we don't have any more questions if that's okay so miss mullinex first you and then
▶ Play
Speaker 366 3:39:35
mr riley and then we're going to represent gray to close for this bill thank you i just wanted an opportunity to answer i think it is an answer to both your question and Representative Payton's in regard to any provisions that we can agree on or you ask about a specific provision. The company that we represent, Express Scripts, does not object to the provision that requires affiliate pharmacies to be reimbursed no greater than other pharmacies are reimbursed. So I just wanted to make that clear. And Mr. Rowley, you have something
▶ Play
Chair Unverified 3:40:07
to add or say? In response
▶ Play
to Representative Henderson's question, this bill was actually negotiated two years ago. It just hasn't worked. And in the last two years, the under-cost payments have accelerated greater than they've ever been. We've, for 20, 25 years with PBMs, this has not been a problem. We've always had a few under-cost scripts. We understand that's going to happen occasionally, but then there was responsiveness. But in the last two or three years, it's been like it's become part of the system to control costs by paying pharmacists under cost. And I think they realize we really have
▶ Play
Speaker 123 3:40:45
no power in the equation. All right. I don't want to go too awful far here. Members, there's no further questions. I'm
▶ Play
Chair Unverified 3:40:51
going to ask Representative Gray to close for her bill.
▶ Play
Thank you, Mr. Chair, committee members. In closing, some of the things that I would like to say, just quickly, I know everyone needs to get out of committee. Mr. Horn with CVS was just to talk to some of his points. He was talking about plans that have pass-through pricing. That is correct, but they also set the prices. So, I mean, you can have pass-through pricing, but then the PBM sets the pricing. Guaranteed profit is nowhere in this bill. The only time that we are saying that they have to pay profit, But if we appeal that medication and we can prove that that medication is not available in the market anywhere else at the price that they say it is, we are requesting that they change the price because some of the amounts that we've seen have been arbitrary. I've got a printout from a pharmacy in the state of Arkansas. Six months, it shows me the price of the medication. It was like $235, $233, $236, and then in December it dropped to $120. But their acquisition costs did not change. That's an arbitrary number, and so when they appeal, Mr. Horn did say that CVS's rate is more than express scripts, which is 18%, but he did not say how much. Let's say it's 20% or 25%. That's still not very much on the amount of these claims. I actually have a pharmacist that I'm personal friends with that I asked them to come testify, and they were afraid that if they came and testified, whether or not this bill passed, that they might lose their contract. and I've got one Renee Logan that's in the audience she actually had a large list that she had things that she had prepared to talk about but we're out of time and she's not going to be able to talk this issue does not affect me I took this on because of my love for what pharmacies do in my town they help with fundraisers they help with anything they can they come in after hours to fill a prescription they are part of the foundation of our towns, and all I'm hearing from them is that they are becoming unable to actually make the payments on their buildings to pay their bills properly, and they're being squeezed to the point of having to close their doors. That's all this is to address. I need those pharmacies open. My husband's a family practice physician. We need those pharmacies open, able to fill prescriptions. It benefits my patients to have those local pharmacies open. I would like to say that they allude to the fact that if they could have worked with us that we might have could have come to an agreement. This bill's been filed for quite a while. I met with a CVS representative for approximately 15 minutes. They left to go to another meeting and I did not hear back. I have met with the lobbyists from both sides multiple times. I met with Express Scripts, two representatives with express scripts with myself and Senator Caldwell and the Pharmacy Association. We've made two amendments to this bill already based on comments that they had and issues that they had. I was actually told last night that I had not amended the bill. I said, you can go out and look. You can see it engrossed in the bill. We have worked with them on this. And finally, they say that it's going to increase the cost. I've been asking now for two weeks because this is all I've done for two weeks to show me where that increased cost was. No one can provide me with where that increased cost was. I actually make a statement. I think it will lower the cost. If you've got a pharmacy who can refuse to fill a prescription, I've got Renee that was going to talk. There's right here, she says prescription ran through for a patient and it was paid $43.60. She went to order the medication and the cost was $595. It's a $110 loss. Not to mention the cost of goods sold, which is the time for, you've got to pay for your pharmacy tech, your overhead. So you add that into the equation, it's even more money that she would have lost. I say, if she's able to say, no, I'm not going to fill this prescription. I'm sorry. You know, You'll have to take it, send it to the mail-in pharmacy. A lot of these have mail-in pharmacies. When she mails that into the pharmacy and based on the second piece of this legislation, they're required to fill it at their pharmacy at the same rate they were going to pay her, they'll either take a loss or they'll raise the cost. I think these two major pieces in this legislation will balance out and help regulate the cost, and maybe regulate's not a good word stabilize the cost to some degree so with that I'm very passionate about this I have no stake in the game aside from just helping my patients and helping my local communities but I would appreciate a good vote and I thank you all very much for your time
▶ Play
Chair Unverified 3:46:05
members for an explanation of the bill what's the will of the committee your motion
▶ Play
is what we have a motion to do pass from Representative Ward Discussion on the motion? Representative Hammer? I'd like to speak to the motion. I want an interpretation from the chair of the motion, please. Okay. Based on testimony here today, if we vote for this bill, then there is in some essence that the pharmacists are going to have a little bit more control or guaranteed reimbursement rate. If we vote against this bill, then based on testimony, the PBMs are being guaranteed that they're not going to be put in a position to have to lose money. So it's kind of like a derned if we do and we're derned if we don't to the principle that we don't want to guarantee profit for one or the other. Am I correct or incorrect in that to the Chair's opinion? I don't know that I
▶ Play
Chair Unverified 3:46:59
want to try to interpret your interpretation, Representative Hammer. I think you've spoke. I'm not sure if you just spoke which way you spoke on the bill.
▶ Play
But did he confuse people more? If we vote for this bill, then basically we are guaranteeing the pharmacists, or depending on who you listen to, that they will be able to be reimbursed to the rate of the cost of the prescription. But if we vote against it, because what I heard the PBM say a while ago was they don't lose money. They may take a haircut. We don't know how short it is, but we're guaranteeing that they're not going to lose money. So depending on how you vote, it depends on which side you line up. Am I
▶ Play
Chair Unverified 3:47:49
right or wrong on that? Well, I don't think a vote against it would guarantee that the PBMs not lose money. Because there's nothing in the current statute that says that PBMs have to make a profit or have to break even or can't make a profit or anything else. So not voting on this, there's nothing in statute that currently says anything about how much money PBMs do or do not make or how their prices are set. All right. Everyone thoroughly confused more? Good. Any further discussion on this motion? Representative Bentley? I just want to quickly say since I've been here my pharmacy in Ola
▶ Play
has gone under and my pharmacy in Plainview has gone under and my constituents have to drive 20-25 miles I'm pleading we need to beg for this we need our small town pharmacies and I want to give them some help so I would encourage you guys for a yes vote Alright with
▶ Play
Chair Unverified 3:48:45
our discussion on the motion all in favor
▶ Play
Speaker 9 3:48:47
say aye. Aye. All opposed No Ayes have it Representative
▶ Play
Harris, you're up next. Thank you, committee and committee members. I appreciate your time. I've been in and out. I have an amendment to put the language into the bill. We're talking about House
▶ Play
Chair Unverified 3:49:27
Bill 1555, members. Yes. And I'd like Kim
▶ Play
Arnold to come to the table. Please. House Bill 1555 is amended on
▶ Play
Chair Unverified 3:49:38
the tablet, members. This is our last special order of business, and I promise you the last bill we're going to hear today. Members, do we have any questions about the amendment? Hearing none, is there any what's will of the committee? I have a motion to adopt the amendment from Representative Meeks. All in favor say aye. Any opposed? The amendment is adopted. You can present 1555 as amended. If you have a guest, I'm sorry, she's welcome to introduce herself for the record and
▶ Play
give testimony. All right. I'd first like to start out just real quickly just to say why I'm involved. I've been on public health for the last session and have heard testimony on this, and I had a choice of finding a new sponsor for this bill. But want to make it clear, besides the critics and the untruths out there, I have lived with the fact of mental health in my home, and despite what has been told of how we dealt with the situations in our home, we know what mental health is like in dealing with medicines and prescriptions in our home, dealing with mental health. and the changes of prescriptions is highly important to a child with mental health and how that can be critical to the patient. And this bill just simply talks about where that discussion needs to be taking place. And this is no laughing matter. And I think it needs to be done in the doctor's office and not done at the pharmacy. And so that's why I completely support this bill. And since the time of what has happened in our own situation, I have decided to go back to grad school to get my master's in professional counseling and have been working on that. And I have seen how important it is medication is in the importance in professional counseling and how switching out medications is detrimental to the patients when there is a chemical imbalance. And so that's why I would like Kim Arnold to speak. She has more knowledge and has studied this for years and brings a lot more expertise to the subject. Thank
▶ Play
you, Mr. Chair and representatives. My name is Kim Arnold, and I'm the state executive director of NAMI Arkansas. That's the National Alliance on Mental Illness here in Arkansas. We provide, our organization provides support, education, and advocacy for individuals with mental illness and their family members. And I'll be the first to say here that we are not therapists, psychiatrists, attorneys, or pharmacists. But what is important is that we run a support line for individuals. Anybody can call it. I call it a warm line because individuals, mostly family members or individuals with mental illness or their family members, call that. And I can tell you from the calls we take in our office, most frequently what they're talking about is the medications that their loved ones take or they themselves take if they're the one with the mental illness calling. And what this particular bill does is we're just asking for this small exemption because an individual with mental illness or a family member will tell you that antipsychotics are not alike and they're not the same. And one can't be, they don't act the same way for each other and they don't act the same way from one person to the other. and sometimes it takes years to find the right medication in order to find out what works, and that's what's really important for recovery. And so what we're really asking for is just this small, small exemption of antipsychotic medication to protect a vulnerable population of individuals with serious mental illness, And my thought on that would be that any consequences that would be, whether it is that the medication would, a prescription would accidentally get, may therapeutically substitute on it or something like that would occur, any consequences would be to the individual with serious mental illness. And so that's why I would ask for anything in favor of this. we advocate for this for a very vulnerable population who have serious mental illness and would take antipsychotic medication. And I thank you for your time, and we'd be happy to take any questions that you may have. Representative Boyd, you're
▶ Play
recognized. Mr. Chair, I'm going to have a few questions, so just cut me off when I'm done, okay? Gladly. All right, so first of all, to your knowledge, Has this ever been done in the state of Arkansas where an antipsychotic medication has been substituted for another antipsychotic medication?
▶ Play
To my knowledge, this is from Act 274 of the legislative session in 2013, where it was allowed where a medication by a doctor's prescription could have, may therapeutically substitute, placed on that. So I don't know, but the option does exist. So whether or not it could, my concern, and for individuals and family members, is that an individual may not be the guardian who goes and picks up the prescription. The way that law reads at this point is that the medication that would be substituted would be identical in nature. And when these things went through rules and regs, some very simple things that I asked for, or just even whether it was on choice or time or things, those were not even given. So at this point, I'm not aware of anything because I don't have that information.
▶ Play
Okay, so you brought up some valid points. So first of all, can this substitution take place without patient consent?
▶ Play
It could not take place without patient consent. my concern is whether or not they would understand or the stigma of having that conversation
▶ Play
in front of the pharmacist. Could one easily interchange one psychotic, antipsychotic for another without consulting with a physician to understand the full history
▶ Play
of the patient? Under the law as it is now in Act 274, it does allow that. if there were to become where it would may therapeutically substitute would be placed on the
▶ Play
prescription. So your concern is really this, the law says it could in theory happen, but we haven't established that it has happened, that maybe in some random situation it possibly could happen. So we're changing the law because of this random concern that maybe it would happen?
▶ Play
Well, actually, Representative, I think the rules and regulations, this bill has actually been around since 2013, and the rules and regulations were just established and just went into perhaps January, so it's been a very short time. My concern is that anything that were to happen, a pharmacist may have a license, and if there were inappropriate things going on, that the pharmacist would be covered. a physician would be covered by a medical license, and that would be who would lose in this would be the patient because their life and their recovery would be at loss at this because they
▶ Play
Speaker 402 3:58:13
would face a relapse. One final
▶ Play
Chair Unverified 3:58:15
question and then I'll... One final,
▶ Play
we've got a couple more, so go ahead. With this overly broad definition of antipsychotic medications, could there be a situation where someone were prescribe something that had nothing to do with psychosis, like, say, nausea, but the insurance company didn't want to pay for, say, promethazine. They wanted to pay for, say, prochlorperazine, but this additional regulation would prevent that substitution from happening. You are completely out
▶ Play
of my range for every disclaimer that I just made, Representative. What we do know is that the law, the way it used to exist and the way that it still would exist, is that the substitution could still occur where the prescriber and the individual could still have that conversation and the generic could still occur as it did. And certainly if a person went to the pharmacist and said, you know, gosh, I can't afford this, is there something, then the pharmacist would make that phone call back to the prescriber and have that conversation so that they could have all of the medical history of that patient at that time and have that conversation. Mr. Chair, if
▶ Play
I also may say that we are, from my understanding, we are only one of two states that do this.
▶ Play
Chair Unverified 3:59:47
All right. We're going to move on to Representative McGee. You're recognized. Thank you, Mr.
▶ Play
Speaker 291 3:59:55
Chair. As I read through the previous bill, the previous language, if, in a way I understand it, the patient, whoever the patient is, they show up at a pharmacist and they show up at Representative Boyd's pharmacy. He's going to make a therapeutic equivalent drug substitution. He has to call. He has to call the prescribing provider. So why would we make an exemption for a drug that he has to call? That's what it says. He has to call the prescribing provider to get permission, and then he also has to, within 72 hours, I think it is, has to, in written form, provide to the prescribing provider that he did make that substitution. So the doctor still has the control of, I want this drug or that drug. I can't see how he can make that change without letting me know as a physician.
▶ Play
My understanding is that with Act 274 of the 2013 legislature that the definition of therapeutically equivalent was changed and that it allowed any medication within the therapeutic class so it could be substituted and so that there is not where the pharmacist must call the doctor and change that. In fact, that's been eliminated so that if it is a lower cost and if it is where the individual may therapeutically substitute or therapeutic substitution is allowed, I think those are the two terminologies that can be used, then the pharmacist, if it is a lower cost medication available could make that substitution. He does have to inform the patient that the substitution has been made and that it is equivalent in the way it behaves and the act and how it treats the illness. And, again, our concern is just for that small vary that the antipsychotics for individuals with serious mental illness. but they I
▶ Play
Speaker 291 4:02:11
don't know I don't know what act 274 said or whatever all I know is where this was placed in the statute or where this was placed to change and according to this it says the prescriber it has to be notified before it's
▶ Play
Speaker 195 4:02:26
changed I'd have to get some further information on that
▶ Play
Chair Unverified 4:02:32
I'm going to move over to represent Peyton and then
▶ Play
Love and then Warren Law Thank you Mr. Chair Representative Boyd touched on the big question in my mind is who gets to determine what is an antipsychotic drug and where does the list come from and the definition my memory is not as good as I'd like it to be but a few months ago I was down here for some discussion on this during the interim and I heard testimony from several people and I'm pretty sure you were one of them And among that testimony, somebody was claiming antibiotics and other drugs sometimes have an effect on patients that have psychotic problems that they're being treated with. And they were giving testimony to the, they were arguing that, you know, you never know what drug could be the drug that helps in certain situations. So I'm sure whoever that person was that was given that testimony would have a very broad list. Can you tell me where we're going to get the list and who's going to
▶ Play
determine what is an antipsychotic drug? Again, I'm not a pharmacist, but there are lists of antipsychotic medications. Does
▶ Play
this law or the change reference a list of any
▶ Play
Speaker 401 4:03:55
kind? Not to my knowledge. Representative Payton,
▶ Play
I remember the meeting. It was, I believe, back in November. I'm not sure if Representative Link remembers, but it was in rules and regs, and I'm sure there is a list, but I can't recall that right now. And we all, the pharmacist knows he has it, what medicines combine with different medications, I would hope, because when I get my blood pressure medicine, they know what interacts with other medications, so I'm sure the pharmacist would know.
▶ Play
Well, if we're sure the pharmacists would know, then why don't we
▶ Play
trust them to make the decision? I think what, to Ms. Arnold's testimony, is the fact that these patients that may have a mental illness, are they capable to make that decision right there on the spot when they can actually have a sit-down, comfortable conversation within the doctor's office, within the psychiatrist's office, wherever they may be with to have that one-on-one session instead of in a line where we've all been at Walmart or at Walgreens or at the pharmacies where there's people behind you and there's HIPAA laws but you know Justin Harris please come to the front your prescriptions ready and that person's here in all of my history and you're like please be a little quieter I don't want now that my name's real famous out there, come on forward. And so that person with that stigma doesn't want to know that that person behind them, you know, is on a psychotic medication. And I think that's to the point of this bill is that, you know, now we're going to have this long, drawn-out conversation, and maybe they're not able to have that conversation in line. And so we're wanting to have it at the doctor's office. It's not that necessarily there's not going to be a changeout, but it needs to be had at the doctor's office so they're aware
▶ Play
of what can happen. Thank you. Representative Payton, there was a discussion, and there may be a reference to that. One of the things we did talk about is the side effects that some of the antipsychotic medications, I don't remember a conversation about antibiotic, but antipsychotic medications do have different side effects, And we did discuss those things. For example, some antipsychotic medications can have side effects that are more sedating. And that may be unnecessary due to someone who has more aggravating symptoms. And so you would want a medication that has an antipsychotic medication that keeps that sedative feature rather than prescribing a medication that has more aggravating features or that doesn't have that feature. There may also be a side effect for one that someone chooses because it causes an increase in either for a heart condition or a diabetes or something like that. So there was that discussion. I do remember that one. I wanted to clarify that. All
▶ Play
Chair Unverified 4:07:06
right. Members, we have more people signed up to ask questions. I'm thinking we might want to bring up someone to speak. We've got several to speak for and against this I'm thinking we might want to bring up persons to speak against this Kind of get the other side of this debate going We will leave this place in 12 minutes Period It's not even debatable And I'd like to be able to get both sides of this So Mr. Mark Riley you've signed to speak against this Would you please take them to the table Obviously we know who you are but
▶ Play
introduce yourself for the record Thank you Mr. Chairman Members of the committee I'm Mark Riley with the Arkansas Pharmacists Association Make this as brief as possible We worked on this bill for four years It's a process bill. I've listened to all the horror stories, and they exist around mental illness. I have members of my family that have problems. But this bill has nothing to do with that. This bill is a process that takes a current process that will continue to go on, whether this bill exists or not, that now takes six hours, eight hours, 24 hours from calling back and forth between the pharmacy. This drug's not on the formulary. Doc, do you want to use this one? This bill turns that process into ten minutes. We have to talk to the patient. It has to save the patient money. There's all kinds of safeguards in it. Now, the doctor has to write legibly on the prescription, may therapeutically substitute or MTS very prominently before it even kicks in. I don't know of a psychiatrist anywhere with antipsychotic medicines that are a problem that's ever going to do that. The problem when we start exempting a class on a bill like this is it's a slippery slope. First of all, we've already talked about antipsychotic medicines are spread out all over the place. You know, there are antidepressants that were originally in it, and there's antidepressants that are used for bedwetting. I mean, there's all kinds of problems with picking a class of drugs. And then it's a slippery slope. So is the next, is it for, you know, is it HIV patients? Is it antileptics? And before long, we've got a bill that now that there is no therapeutic substitution. Therapeutic substitution bill was intended to do one thing, and that's when a physician was comfortable in a class of drugs saying, I'm starting them on this drug. We don't know which one's going to work. We might as well go with the one that costs the patient the less money. It gives the pharmacist the right to do that, send that message back to the physician. This is what was chosen. This is the one their formulary was
▶ Play
Chair Unverified 4:09:31
covered, and that's all it does. Any questions for Mr. Riley? Seeing none, we have Catherine Darling signed to speak for this bill.
▶ Play
Speaker 410 4:09:39
Mr. Chairman, members of the committee, thank you. My name is Catherine Darling. I am a psychiatric nurse practitioner. I've been a clinician since 1998. I'd like to address some of the questions that I've just heard. First of all, if there's a potential for a therapeutic substitution, that is a potential for a problem. All of them, all of the patients that receive antipsychotics are not equal, and all of the antipsychotics themselves are not equal. There are a number of factors that, as a prescriber, that allow me to select a medication. We choose side effects, sometimes for the advantage of the patient. Sometimes we have metabolic risk factors that we will select one medication over another. I understand that the pharmacist must contact the provider before, not before, but after a substitution is made. It is not required. What they do now is if they feel like a substitution is warranted, a pharmacist can now contact a provider and say, hey, do you mind if we do this? This changes, this bill, this law that is now law, changes this process. This substitution can be made before the provider knows. And I would like to speak on behalf of the patient. The patient is a vulnerable population. These people have a 20 to 30-year shorter lifespan than the average person. That means that your person next door who has schizophrenia may die at the age of 45 or 50 or 55. It's so important to get the right medications on board. The risk factors for some antipsychotics increase blood pressure, they increase dyslipidemia, and increase the risk factor for cardiovascular disease, which is stroke, heart attacks. It can also increase dementia, both Alzheimer's type and vascular dementia. It's so important to get the right medication. Not all medications work for the same person. We use genetic testing sometimes to select an antipsychotic. The pharmacist does not have that testing available to make those decisions. If I choose an antipsychotic that is metabolized poorly, then I can actually put the patient at risk for severe consequences. That is my responsibility as a provider and a clinician who is writing this prescription. I ask that we remove the potential for a therapeutic substitution by a pharmacist. I have no problems with pharmacists. I dialogue with them constantly. I have done that for 20 years. When a pharmacist thinks something and they call me and we have a discussion about it, and we can come to a mutual conclusion that, yes, that is fine. I do that all the time. But I do not feel as a psychiatric provider that there is such a thing as a therapeutic substitution for an antipsychotic. To answer another question, I would like to say that the antipsychotics are labeled as antipsychotics, and we're talking about antipsychotics. We're not talking about psychotropics, which can include antidepressants and a lot of other medications. We're talking about medications that have the FDA indication for an antipsychotic.
▶ Play
I'll take any questions. Representative Boyd, you're recognized. Is promethazine an antipsychotic? Well,
▶ Play
Speaker 410 4:13:04
it's not listed as an antipsychotic that I know of. And if it is, I don't know that. It's listed as an anti-emetic, as far as I know. And you may know the answer to that, but it is not an
▶ Play
Chair Unverified 4:13:20
anti-psychotic. Seeing no further questions, we have Mr. Mike Rose signed to speak for this bill. I'm just going to drop this in your lap. Be sure. I'm going to
▶ Play
drop it in your lap. Introduce yourself for the record. is mike rose and i suffer from mental illness i am 55 years old i take medication and i'm not afraid to speak about it but what representative harris is doing is a good bill that law is a good law we need to take that law and take his bill and put it together and give it more teeth If you really want to know how I feel after session, come and talk to me. Members, any
▶ Play
Chair Unverified 4:14:10
questions? Seeing none, Representative Harris, do you recognize close for your bill? I know you
▶ Play
all want to hear. I just would appreciate a good vote. Only we're one of two states that do this. We need to fix
▶ Play
Speaker 416 4:14:26
this, so I'd appreciate a good vote. Thank you. All right. Thank
▶ Play
Chair Unverified 4:14:30
you, Representative Harris. Any, what's the will of this committee? Representative Fite, you recognize for a motion. We have a motion do pass from Representative Fite on the table. Is there any discussion of that motion? Seeing and hearing none, all in favor say aye. Any opposed, say nay. Chair's going to rule no's habit. Members, thank you for four and a half hours of committee meeting. I'll see you on the House floor, and I'll see you Tuesday at 10 o'clock. Amen.
▶ Play

Agenda

HB1953

1:28 - 2:51 5 segments 3 speakers

HB1540

2:51 - 5:23 10 segments 3 speakers

HB1491

5:23 - 13:01 22 segments 6 speakers

HB1343

13:01 - 35:09 79 segments 11 speakers

SB133

35:09 - 1:58:14 244 segments 18 speakers

HB1747

1:58:14 - 2:53:07 155 segments 17 speakers

SB688

2:53:07 - 3:49:39 167 segments 16 speakers

HB1555

3:49:39 - 4:15:04 80 segments 13 speakers

Documents

No documents posted.

Speakers

Chair Unverified
149 segments
Representative David Fielding Unverified
2 segments
Representative Robin Lundstrum Unverified
5 segments
Representative Justin Boyd Unverified
17 segments
Speaker 31
1 segment
Tom Olmsted Unverified
9 segments
Representative Charlene Fite Unverified
8 segments
Speaker 60
36 segments
Speaker 66
1 segment
Representative Fredrick J. Love Unverified
12 segments
Speaker 95
1 segment
Representative Dan Sullivan Unverified
23 segments
Speaker 102
1 segment
Representative John Payton Unverified
27 segments
Representative Jeff Wardlaw Unverified
3 segments
Speaker 97
1 segment
Senator Cecile Bledsoe Unverified
64 segments
Representative Stephen Meeks Unverified
64 segments
Representative Deborah Ferguson Unverified
20 segments
Representative Kim Hammer Chair Unverified
54 segments
Speaker 169
1 segment
Speaker 174
17 segments
Speaker 94
1 segment
Speaker 223
1 segment
Representative Ken Henderson Chair Unverified
6 segments
Justin Allen Unverified
9 segments
Speaker 246
11 segments
Bill Phillips Unverified
19 segments
Speaker 167
1 segment
Speaker 262
24 segments
Speaker 260
1 segment
Speaker 273
10 segments
Speaker 277
1 segment
Speaker 283
1 segment
Speaker 287
16 segments
Speaker 291
12 segments
Speaker 311
1 segment
Speaker 315
3 segments
Speaker 230
1 segment
Representative Michelle Gray Unverified
20 segments
Speaker 345
40 segments
Speaker 352
1 segment
Polly Martin Unverified
2 segments
Speaker 366
12 segments
Speaker 370
1 segment
Speaker 376
1 segment
Speaker 123
1 segment
Representative Mary Bentley Unverified
1 segment
Speaker 9
1 segment
Representative Justin T. Harris Unverified
16 segments
Kim Arnold Unverified
22 segments
Speaker 402
1 segment
Speaker 195
1 segment
Speaker 401
1 segment
Speaker 410
7 segments
Mike Rose Unverified
2 segments
Speaker 416
1 segment